B. Maron

M. Link, B. Maron, W. Roberts, 2007, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications

M. Link, B. Maron, A. Alsheikh-Ali, 2017, Journal of cardiovascular electrophysiology.

Prevalence and significance of an abnormal S-T segment response to exercise in a young athletic population.

R. Bonow, B. Maron, S. Epstein, 1983, The American journal of cardiology.

Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.

Fernando Costa, Barry J Maron, William L Haskell, 2007, Circulation.

Abnormalities Eligibility and Disqualification of Competitive Athletes With Cardiovascular Recommendations Revisited: A Comparison of U.S. and European Criteria for

B. Maron, D. Zipes, A. Pelliccia, 2008 .

Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.

B. Maron, D. Zipes, A. Pelliccia, 2008, Journal of the American College of Cardiology.

Perspectives on the failure of pharmaceutical and medical device industries to fully protect public health interests.

Barry J Maron, B. Maron, R. Hauser, 2007, The American journal of cardiology.

86 – Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

B. Maron, Barry J. Maron, Barry J Maron, 2014 .

Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy.

B. Maron, C. Gornick, R. Hauser, 2005, Heart rhythm.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

J. Seidman, J. Saul, W. Roberts, 2009, JAMA.

Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy.

B. Maron, P. Spirito, 1999, Journal of the American College of Cardiology.

Diastolic Mechanisms for Systolic Dysfunction During Exercise

B. Maron, S. Bacharach, A. Cuocolo, 2005 .

Flail mitral valve and sudden cardiac death.

B. Maron, K. Harris, 2000, Journal of the American College of Cardiology.

Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction.

B. Maron, M. Maron, J. Lesser, 2008, The American journal of cardiology.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.

B. Maron, R. Kovacs, A. Braverman, 2015, Circulation.

Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2017, Circulation.

Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.

B. Maron, M. Maron, I. Olivotto, 2010, The American journal of cardiology.

Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy.

B. Maron, M. Maron, J. Lesser, 2015, The American journal of cardiology.

Experimental production of aortic valvular stenosis. Short-term and long-term studies in dogs.

J. Copeland, V. Ferrans, B. Maron, 1974, The Journal of thoracic and cardiovascular surgery.

Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome.

B. Maron, M. Sherrid, M. Maron, 2020, The American journal of cardiology.

Alcohol septal ablation: in which patients and why?

B. Maron, P. Spirito, J. Rossi, 2017, Annals of cardiothoracic surgery.

Obstructive hypertrophic cardiomyopathy associated with minimal left ventricular hypertrophy.

R. Bonow, B. Maron, S. Epstein, 1984, American Journal of Cardiology.

Significance of Left Ventricular Outflow Tract Cross‐sectional Area in Hypertrophic Cardiomyopathy: A Two‐dimensional Echocardiographic Assessment

B. Maron, P. Spirito, 1983, Circulation.

Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography.

B. Maron, P. Spirito, 1984, The American journal of cardiology.

Initial Results of Combined Anterior Mitral Leaflet Plication and Ventricular Septal Myotomy‐Myectomy for Relief of Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy

B. Maron, R. Cannon, H. Klues, 1992, Circulation.

Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy.

B. Maron, S. Epstein, A. Morrow, 1983, European heart journal.

Unusual distribution of left ventricular hypertrophy in obstructive hypertrophic cardiomyopathy: localized posterobasal free wall thickening in two patients.

B. Maron, F. Chiarella, C. Vecchio, 1985, Journal of the American College of Cardiology.

Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.

B. Maron, D. Rosing, P. Spirito, 1984, Circulation.

Simultaneous occurrence of mitral valve prolapse and systolic anterior motion in hypertrophic cardiomyopathy.

B. Maron, J. Panza, 1991, The American journal of cardiology.

Cross-sectional Echocardiography in the Diagnosis of Congenital Heart Disease: Identification of the Relation of the Ventricles and Great Arteries

J. Griffith, W. Henry, B. Maron, 1977, Circulation.

Prognosis of Surgically Corrected Coarctation of the Aorta: A 20‐Year Postoperative Appraisal

R. Rowe, B. Maron, E. Mellits, 1973, Circulation.

Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors.

C. Autore, B. Maron, C. Rapezzi, 2014, The American journal of cardiology.

Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, R. Chan, 2015, The American journal of cardiology.

Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities.

J. Mitchell, B. Maron, 1994, Medicine and science in sports and exercise.

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2).

R. Bonow, B. Maron, M. Leon, 1987, The New England journal of medicine.

Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities.

J. Mitchell, B. Maron, J. H. Mitchell, 1994, Journal of the American College of Cardiology.

Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation.

B. Maron, E. Lakatos, P. Spirito, 1992, The American journal of cardiology.

Long-term consequences of the right ventricular pacing mania of the 1990s for obstructive hypertrophic cardiomyopathy.

M. Josephson, B. Maron, 2014, The American journal of cardiology.

Late results of aortic valvotomy for congenital valvar aortic stenosis.

B. Maron, R. E. Clark, R. Robbins, 1990, The Annals of thoracic surgery.

Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy.

B. Maron, M. Leon, R. E. Clark, 1989, The Annals of thoracic surgery.

Criminal consequences of commotio cordis.

B. Maron, M. Mitten, Catherine Greene Burnett, 2002, The American journal of cardiology.

Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy.

M. Link, B. Maron, M. Maron, 2011, Journal of the American College of Cardiology.

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.

M. Link, L. Jordaens, H. Heidbuchel, 2013, Circulation.

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry

M. Link, H. Heidbuchel, H. Calkins, 2013, Circulation.

Role of Streptomycin‐Sensitive Stretch‐Activated Channel in Chest Wall Impact Induced Sudden Death (Commotio Cordis)

Paul J. Wang, M. Link, B. Maron, 2005, Journal of cardiovascular electrophysiology.

Expanding Pathobiological Mechanisms in Hypertrophic Cardiomyopathy to Explain Heterogeneity: JACC Review Topic of the Week

J. Loscalzo, B. Maron, M. Maron, 2019 .

Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease.

B. Maron, R. E. Clark, L. Permut, 1989, Journal of the American College of Cardiology.

B. Maron, R. Kovacs, A. Braverman, 2015, Journal of the American College of Cardiology.

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Michael J Ackerman, Barry J Maron, J. Towbin, 2004, Circulation.

Eligibility and Disquali fi cation Recommendations for Competitive Athletes With Cardiovascular Abnormalities : Preamble , Principles , and General Considerations

B. Maron, 2015 .

Treatment of Hypertrophic Cardiomyopathy

M. Link, B. Gersh, W. Stevenson, 2011 .

Role of Exercise Testing in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, I. Olivotto, 2017, JACC. Cardiovascular imaging.

Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes.

B. Maron, A. Pelliccia, F. Culasso, 2010, Journal of the American College of Cardiology.

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2019, Journal of the American Heart Association.

Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.

B. Wessler, B. Maron, M. Maron, 2019, Circulation. Cardiovascular interventions.

Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?

B. Maron, M. Maron, C. Semsarian, 2015, Journal of the American College of Cardiology.

HLA linkage vs association in hypertrophic cardiomyopathy. Evidence for the absence of an association in a heterogeneous Caucasian population.

J. Gardin, J. Gottdiener, B. Maron, 1982, Chest.

Spontaneous Animal Models

B. Maron, G. Thiene, C. Basso, 2007 .

Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.

B. Maron, I. Olivotto, F. Cecchi, 1997, Heart.

Ventricular septal crypt in hypertrophic cardiomyopathy.

B. Maron, J. Lesser, J. Lindberg, 2010, European Heart Journal.

Absence of left ventricular wall thickening in athletes engaged in intense power training.

B. Maron, A. Pelliccia, A. Spataro, 1993, The American journal of cardiology.

Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction.

Michael V. Green, R. Bonow, B. Maron, 1984, Circulation.

Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography.

Michael V. Green, R. Bonow, B. Maron, 1986, Journal of the American College of Cardiology.

Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease.

B. Maron, G. Thiene, C. Basso, 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities.

B. Maron, A. Pelliccia, A. Biffi, 2011, The American journal of cardiology.

Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes.

B. Maron, A. Pelliccia, A. Biffi, 2004, Journal of the American College of Cardiology.

Left Ventricular Hypertrophy in Athletes Physiologic Limits of Left Ventricular Hypertrophy in Elite Junior Athletes: Relevance to Differential Diagnosis of Athlete's Heart and Hypertrophic Cardiomyopathy

B. Maron, P. Elliott, G. Whyte, 2002 .

CLINICAL STUDIES Hypertrophic Cardiomyopathy Development of Left Ventricular Hypertrophy in Adults With Hypertrophic Cardiomyopathy Caused by Cardiac Myosin-Binding Protein C Gene Mutations

J. Seidman, B. Maron, C. Seidman, 2001 .

Patterns of pulmonary venous and transmitral flow velocity in patients with hypertrophic cardiomyopathy.

B. Maron, G. Keren, Barry I. Maron, 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Left ventricular diastolic filling abnormalities identified by Doppler echocardiography in asymptomatic patients with sickle cell anemia.

B. Maron, O. Castro, J. Lewis, 1991, Journal of the American College of Cardiology.

Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening.

B. Maron, J. Lewis, 1990, The American journal of cardiology.

Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy.

B. Maron, D. Goldstein, R. Cannon, 1989, Circulation.

Increased right ventricular wall thickness in left ventricular pressure overload: echocardiographic determination of hypertrophic response of the "nonstressed" ventricle.

J. Gottdiener, B. Maron, J. Gay, 1985, Journal of the American College of Cardiology.

Hypertrophic Cardiomyopathy with Unusual Locations of Left Ventricular Hypertrophy Undetectable, by M‐mode Echocardiography: Identification by Wide‐angle Two‐dimensional Echocardiography

J. Gottdiener, R. Bonow, B. Maron, 1981, Circulation.

AORTIC DISEASE Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation : influence of duration of preoperative left ventricular dysfunction

Michael V. Green, B. Maron, R. E. Clark, 2005 .

Doppler echocardiography for assessing left ventricular diastolic function.

B. Maron, P. Spirito, 1988, Annals of internal medicine.

Epidemiology and clinical profile of Takotsubo cardiomyopathy.

B. Maron, S. Sharkey, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age

W. Manning, B. Maron, M. Maron, 2013, Circulation.

Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease

E. Braunwald, B. Maron, 2012, Circulation.

IMPACT OF OBESITY ON THE PHENOTYPE AND CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY

W. Manning, B. Maron, M. Maron, 2012 .

Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy.

W. Roberts, V. Ferrans, B. Maron, 1975, The American journal of pathology.

Echocardiographic analysis of ventricular septal dynamics in hypertrophic cardiomyopathy and other diseases.

B. Maron, A. Giunta, E. Ciró, 1984, The American journal of cardiology.

LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart

J. Seidman, W. Roberts, B. Maron, 2021, Journal of the American Heart Association.

Clinical Outcome and Phenotypic Expression in LAMP 2 Cardiomyopathy

J. Seidman, J. Saul, W. Roberts, 2009 .

R. Passman, S. Hohnloser, W. Stevenson, 2008 .

THE ATHLETE'S HEART SYNDROME: A NEW PERSPECTIVE

B. Maron, J. Morganroth, 1977, Annals of the New York Academy of Sciences.

Prevention of sudden death for patients with cardiomyopathies another step forward.

B. Maron, C. Semsarian, 2012, Journal of the American College of Cardiology.

Cardiovascular Causes and Pathology of Sudden Death in Athletes: The American Experience

B. Maron, 2000 .

Scope of the Problem of Sudden Death in Athletes: Definitions, Epidemiology and Socioeconomic Implications

B. Maron, 2000 .

Heart disease and other causes of sudden death in young athletes.

B. Maron, 1998, Current problems in cardiology.

Risk profiles and cardiovascular preparticipation screening of competitive athletes.

B. Maron, 1997, Cardiology clinics.

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

R. Bonow, B. Maron, M. Leon, 1985, Circulation.

Maron Hypertrophic Cardiomyopathy : A Systematic Review

B. Maron, 2002 .

Spontaneously Occurring Arrhythmogenic Right Ventricular Cardiomyopathy in the Domestic Cat: A New Animal Model Similar to the Human Disease

B. Maron, G. Thiene, C. Basso, 2000, Circulation.

Valvular aortic stenosis and asymmetric septal hypertrophy: diagnostic considerations and clinical and therapeutic implications.

B. Maron, J. Panza, Barry J. Maron, 1988, European heart journal.

The genetics of hypertrophic cardiomyopathy.

B. Maron, J. Mulvihill, 1986, Annals of internal medicine.

Significance of multiple intercalated discs in hypertrophied human myocardium.

V. Ferrans, B. Maron, 1973, The American journal of pathology.

Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, 2002, Cardiology in review.

Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy

B. Maron, 2000, Current cardiology reports.

Clinical Profile of Commotio Cordis: An Under Appreciated Cause of Sudden Death in the Young During Sports and Other Activities

Paul J. Wang, M. Link, B. Maron, 1999, Journal of cardiovascular electrophysiology.

Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy : A Randomized , Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory

R. Kieval, B. Maron, R. Nishimura, 1999 .

Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.

B. Maron, S. Caselli, M. Santini, 2002, Journal of the American College of Cardiology.

The nuclear membranes in hypertrophied human cardiac muscle cells.

W. Roberts, V. Ferrans, B. Maron, 1975, The American journal of pathology.

Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy.

B. Maron, M. Maron, M. Bristow, 2009, Journal of cardiology.

Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".

B. Maron, M. Maron, E. Rowin, 2019, Circulation.

Sudden death and hypertrophic cardiomyopathy

B. Maron, P. Spirito, 2001, The Lancet.

Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants

M. Link, B. Maron, M. Maron, 2020, Circulation. Arrhythmia and electrophysiology.

Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.

B. Maron, M. Maron, C. Semsarian, 2012, Heart rhythm.

What Causes Hypertrophic Cardiomyopathy?

J. Loscalzo, B. Maron, M. Carnethon, 2022, The American journal of cardiology.

Boxer Dogs : A New Animal Model of Human Disease Arrhythmogenic Right Ventricular Cardiomyopathy Causing Sudden Cardiac Death in

J. Towbin, B. Maron, G. Thiene, 2004 .

Right ventricular cardiomyopathy: another cause of sudden death in the young.

B. Maron, 1988, The New England journal of medicine.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat

M. Link, L. Cooper, R. Bonow, 2015, Journal of the American College of Cardiology.

Ultrastructural features of hypertrophied human ventricular myocardium.

V. Ferrans, B. Maron, 1978, Progress in cardiovascular diseases.

Hypertrophic cardiomyopathy

B. Maron, 1997, The Lancet.

Hypertrophic Cardiomyopathy

B. Maron, L. Poliac, M. Barron, 2002, Lancet.

Prevalence of Arrhythmias During 24‐Hour Electrocardiographic Monitoring Exercise Testing in Patients with Obstructive Nonobstructive Hypertrophic Cardiomyopathy

B. Maron, S. Epstein, D. Savage, 1979, Current problems in cardiology.

Dynamic obstruction to left ventricular outflow: the case for its existence in hypertrophic cardiomyopathy.

B. Maron, S. Epstein, 1987, Zeitschrift fur Kardiologie.

Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophic cardiomyopathy.

B. Maron, S. Epstein, 1986, The American journal of cardiology.

Pathophysiologic mechanisms responsible for the clinical spectrum of hypertrophic cardiomyopathy

R. Bonow, B. Maron, R. Cannon, 1985 .

Echocardiographic Identification of Patterns of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy

J. Gottdiener, B. Maron, S. Epstein, 1982 .

Specificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in large population of patients with other cardiac diseases.

J. Gottdiener, B. Maron, L. W. Perry, 1981, British heart journal.

Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

W. Henry, B. Maron, S. Epstein, 1978, Circulation.

Left Ventricular Outflow Tract Obstruction Due to Systolic Anterior Motion of the Anterior Mitral Leaflet in Patients with Concentric Left Ventricular Hypertrophy

J. Gottdiener, W. Roberts, W. Henry, 1978, Circulation.

Surgical Septal Myectomy Versus Alcohol Septal Ablation: Assessing the Status of the Controversy in 2014

B. Maron, R. Nishimura, 2014, Circulation.

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

M. Link, B. Wessler, B. Maron, 2019, JAMA cardiology.

Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience.

B. Maron, M. Maron, E. Rowin, 2017, Annals of cardiothoracic surgery.

Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest.

B. Maron, S. Epstein, K. Kent, 1980, The American journal of cardiology.

Cardiovascular Diseases That Have Emerged From the Darkness

B. Maron, M. Maurer, M. Maron, 2021, Journal of the American Heart Association.

Sarcolemmal alterations in cardiac hypertrophy and degeneration.

V. Ferrans, B. Maron, L. Buja, 1976, Recent advances in studies on cardiac structure and metabolism.

Task Force 12: legal aspects of the 36th Bethesda Conference recommendations.

B. Maron, M. Mitten, D. Zipes, 2005, Journal of the American College of Cardiology.

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.

B. Maron, S. Epstein, K. Kent, 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.

B. Maron, 1983, European heart journal.

Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.

C. Autore, B. Maron, C. Rapezzi, 2014, The American journal of cardiology.

Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative.

B. Maron, M. Maron, J. Dearani, 2013, The American journal of cardiology.

Is septal ablation preferable to surgical myomectomy for obstructive hypertrophic cardiomyopathy? Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE

B. Maron, 2007 .

Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2020, The American journal of cardiology.

Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2016, Journal of the American College of Cardiology.

CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2012, JACC. Cardiovascular imaging.

Diagnostic Utility of Cardiac Magnetic Resonance Imaging in Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Pattern of Left Ventricular Hypertrophy

B. Maron, J. Lesser, Tammy S. Haas, 2007 .

Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.

B. Maron, J. Lesser, Tammy S. Haas, 2007, Circulation.

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers

Michael A. Burke, J. Seidman, B. Maron, 2020, Open Heart.

Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, The American journal of medicine.

Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy".

B. Maron, M. Maron, 2016, Circulation.

Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

K. Siminovitch, W. Manning, B. Maron, 2014, European heart journal.

Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae.

B. Maron, R. Nishimura, J. Dearani, 2004, The Journal of thoracic and cardiovascular surgery.

β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.

B. Maron, M. Maron, I. Olivotto, 2012, The American journal of cardiology.

Coexistence of late gadolinium enhancement due to myocardial infarction and hypertrophic cardiomyopathy

B. Maron, J. Lesser, David Lin, 2011, Heart.

Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy

W. Manning, B. Maron, M. Maron, 2011, Circulation. Cardiovascular imaging.

DOES FOCAL LATE GADOLINIUM ENHANCEMENT AT THE RIGHT VENTRICULAR INSERTION POINTS MATTER IN RISK STRATIFICATION FOR SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY

E. Cook, W. Manning, C. Autore, 2013 .

Two-dimensional Echocardiographic Assessment of the Idiopathic Hypereosinophilic Syndrome

R. Schooley, W. Roberts, B. Maron, 2005 .

Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse

B. Maron, F. Gaffney, W. Miller, 1985 .

Two‐dimensional Echocardiographic Assessment of the Idiopathic Hypereosinophilic Syndrome: Anatomic Basis of Mitral Regurgitation and Peripheral Embolization

R. Schooley, J. Gottdiener, W. Roberts, 1983, Circulation.

Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study.

J. Hanley, S. Yusuf, K. Bailey, 1986, Circulation.

Hypertrophic cardiomyopathy: one gene … but many phenotypes.

B. Maron, Tammy S. Haas, J. Goodman, 2014, The American journal of cardiology.

Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature.

B. Maron, M. Maron, J. Lesser, 2011, Journal of the American College of Cardiology.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.

B. Maron, M. Ackerman, R. Kovacs, 2015, Journal of the American College of Cardiology.

Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities.

B. Maron, M. Santini, A. Pelliccia, 2015, Heart rhythm.

Disproportionate Ventricular Septal Thickening in Patients with Systemic Hypertension

B. Maron, S. Epstein, J. Edwards, 1978 .

Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine.

S. Ommen, B. Maron, M. Sherrid, 2022, The American journal of cardiology.

Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.

N. Smedira, M. Desai, S. Ommen, 2022, The American journal of cardiology.

Global Dissemination and Implementation of Contemporary Management Principles for Hypertrophic Cardiomyopathy and Role of the International HCM Summit.

B. Maron, M. Maron, E. Rowin, 2022, The American journal of cardiology.

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

B. Maron, M. Sherrid, M. Maron, 2022, Journal of the American Heart Association.

Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?

B. Maron, M. Maron, E. Rowin, 2022, Asian cardiovascular & thoracic annals.

Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2021, The American journal of cardiology.

Is Regression of Left Ventricular Hypertrophy Really a Good Thing for Patients with Hypertrophic Cardiomyopathy?: The Emerging Mavacamten Story.

B. Maron, M. Maron, E. Rowin, 2021, The American journal of cardiology.

After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease with Low Mortality and Morbidity.

B. Maron, M. Maron, E. Rowin, 2020, The American journal of cardiology.

Daughter-mother tako-tsubo cardiomyopathy.

B. Maron, S. Sharkey, D. Lips, 2013, The American journal of cardiology.

Permanent Pacing in Patients with Hypertrophic Cardiomyopathy

B. Maron, D. Gilligan, 1999 .

Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment?

B. Maron, 1996, Journal of the American College of Cardiology.

Intracytoplasmic junctions in cardiac muscle cells.

V. Ferrans, B. Maron, L. Buja, 1974, The American journal of pathology.

Electrophysiologic Manifestations of Ventricular Tachyarrhythmias Provoking Appropriate Defibrillator Interventions in High‐Risk Patients with Hypertrophic Cardiomyopathy

G. Boriani, B. Gersh, B. Maron, 2007, Journal of cardiovascular electrophysiology.

Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, Seminars in Thoracic and Cardiovascular Surgery.

Arousal and nonarousal enuretic events.

K. A. Blinn, B. Maron, E. Ornitz, 1969, The American journal of psychiatry.

Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2021, Journal of cardiovascular electrophysiology.

Hypertrophic Cardiomyopathy

B. Maron, P. Thompson, 2002, The Physician and sportsmedicine.

Hypertrophic cardiomyopathy: the great masquerader. Clinical conference from the Cardiology Branch of the National Heart, Lung, and Blood Institute, Bethesda, Md.

J. Gottdiener, B. Maron, S. Epstein, 1978, Chest.

Cardiovascular consequences of the aging process.

B. Maron, J. Lewis, Lewis Jf, 1992, Cardiovascular clinics.

A Lethal Blow to the Chest as an Underdiagnosed Cause of Sudden Death in United Kingdom Sports (Football, Cricket, Rugby).

M. Sheppard, B. Maron, N. Woodford, 2019, The American journal of cardiology.

Size as an Important Determinant of Chest Blow–induced Commotio Cordis

M. Link, C. Bir, B. Maron, 2018, Medicine and science in sports and exercise.

Recurrent commotio cordis: Déjà vu

M. Link, B. Maron, 2015, HeartRhythm case reports.

Global epidemiology and demographics of commotio cordis.

M. Link, B. Maron, N. Estes, 2011, Heart rhythm.

Protecting Our Children From the Consequences of Chest Blows on the Playing Field: A Time for Science Over Marketing

M. Link, C. Bir, B. Maron, 2008, Pediatrics.

Review Article Commotio Cordis

M. Link, B. Maron, A. Alsheikh-Ali, 2007 .

Historical observation on commotio cordis.

M. Link, B. Maron, N. Estes, 2006, Heart rhythm.

Efficacy of bystander cardiopulmonary resuscitation and out-of-hospital automated external defibrillation as life-saving therapy in commotio cordis.

B. Maron, S. Cyran, R. Cilley, 2005, The Journal of pediatrics.

Death in a young athlete due to commotio cordis despite prompt external defibrillation.

M. Link, B. Maron, N. Estes, 2005, Heart rhythm.

Task Force 11: commotio cordis.

M. Link, B. Maron, N. Estes, 2005, Journal of the American College of Cardiology.

The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification.

B. Maron, 2002, Cardiac electrophysiology review.

Survival following blunt chest impact-induced cardiac arrest during sports activities in young athletes.

B. Maron, J. Kugler, J. Strasburger, 1997, The American journal of cardiology.

Aggregates of tubules in human cardiac muscle cells.

V. Ferrans, B. Maron, 1974, Journal of molecular and cellular cardiology.

Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear.

B. Maron, E. Rowin, J. Udelson, 2021, JAMA cardiology.

Survival After Takotsubo, Revisited.

B. Maron, S. Sharkey, 2018, Journal of the American College of Cardiology.

Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction.

B. Maron, M. Maron, J. Lesser, 2012, The American journal of cardiology.

B. Maron, M. Ackerman, R. Kovacs, 2015, Circulation.

Sudden cardiac death in the young

B. Maron, C. Semsarian, B. Maron, 2002, The Medical journal of Australia.

Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.

B. Maron, M. Maron, E. Rowin, 2020, Journal of the American College of Cardiology.

Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2020, The American journal of cardiology.

A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, 2016, The American journal of cardiology.

LQTS and SIDS linkage: clarifying the record.

B. Maron, 2005, The American journal of cardiology.

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy

B. Maron, R. Bach, O. Wever-Pinzon, 2021, Journal of the American Heart Association.

What Do Patients With Hypertrophic Cardiomyopathy Die from?

B. Maron, M. Maron, E. Rowin, 2016, The American journal of cardiology.

Stress-induced cardiomyopathy Stress-induced takotsubo cardiomyopathy Stress-induced apical ballooning syndrome Stress-related left ventricular dysfunction Stress-related cardiomyopathy Stress-related cardiomyopathy syndrome Stress takotsubo cardiomyopathy Emotional stress-induced ampulla cardiomyop

B. Maron, M. Maron, J. Lesser, 2011 .

Cardiomyopathies characterized by evidence of resistance to left ventricular inflow.

B. Maron, J. Moller, J. Edwards, 1980, Catheterization and cardiovascular diagnosis.

Chapter 9. ST Segment Elevation and Sudden Death in the Athlete

C. Antzelevitch, D. Corrado, B. Maron, 2007 .

Hypertrophic cardiomyopathy in man and cats.

B. Maron, P. Fox, 2015, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Preparticipation screening strategies for prevention of sudden death in young competitive athletes: 12-lead ECG makes the difference

D. Corrado, B. Maron, G. Thiene, 2005 .

Importance of the autonomic nervous system in an experimental model of commotio cordis.

M. Link, B. Maron, N. Estes, 2006, Medical science monitor : international medical journal of experimental and clinical research.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.

William J. Bryant, B. Maron, M. Mitten, 2015, Circulation.

Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark.

B. Maron, H. Bundgaard, R. Jabbari, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Importance of Newer Cardiac Magnetic Resonance-Based Risk Markers for Sudden Death Prevention in Hypertrophic Cardiomyopathy:An International Multicenter Study.

Matthew W. Martinez, B. Maron, M. Maron, 2021, Heart rhythm.

PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.

B. Maron, M. Maron, 2020, Journal of the American College of Cardiology.

Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.

M. Link, J. Hodges, B. Maron, 2009, Heart rhythm.

Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease.

W. Henry, B. Maron, S. Epstein, 1978, Circulation.

Congenital Heart Malformations Associated with Disproportionate Ventricular Septal Thickening

V. Ferrans, W. Henry, B. Maron, 1975, Circulation.

Asymmetric Septal Hypertrophy (ASH) in Infancy

W. Henry, B. Maron, S. Epstein, 1974, Circulation.

Profound left ventricular remodeling associated with LAMP2 cardiomyopathy.

W. Roberts, B. Maron, D. Feldman, 2010, The American journal of cardiology.

Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now.

E. Braunwald, B. Maron, M. Maron, 2017, The American journal of medicine.

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients.

A. Kadish, B. Maron, R. Lampert, 2008, Heart rhythm.

Surgical Ventricular Septal Myectomy in the Developing World.

B. Maron, P. Spirito, 2016, The American journal of cardiology.

Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience.

B. Maron, A. Pitsis, V. Kamperidis, 2014, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy.

B. Maron, 2007, Circulation.

Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, JACC. Heart failure.

Coexistence of acute takotsubo syndrome and acute coronary syndrome

T. Henry, B. Maron, M. Maron, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall.

B. Maron, M. Sherrid, J. Lesser, 2010, The American journal of cardiology.

Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.

J. Hodges, B. Maron, K. Shannon, 2009, Heart rhythm.

Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva.

B. Maron, M. Leon, R. Cannon, 1991, The American journal of cardiology.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (&bgr;-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy

W. Manning, B. Maron, M. Maron, 2017, Circulation. Cardiovascular imaging.

Benefit of Cardiac Resynchronization Therapy in End-Stage Nonobstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2019, JACC. Clinical electrophysiology.

Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Matthew W. Martinez, B. Maron, A. Masri, 2022, JACC. Clinical electrophysiology.

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

B. Maron, S. Epstein, K. Kent, 1979, Circulation.

Results of operation for obstructive hypertrophic cardiomyopathy in the elderly. Septal myotomy and myectomy in 20 patients 65 years of age or older.

B. Maron, S. Epstein, J. Koch, 1980, The American journal of cardiology.

Management of hypertrophic cardiomyopathy.

M. Desai, J. Towbin, B. Maron, 1993, Heart disease and stroke : a journal for primary care physicians.

Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2022, The American journal of cardiology.

Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research.

B. Maron, M. Maron, E. Rowin, 2022, The American journal of medicine.

Prevention of Sudden Death in Hypertrophic Cardiomyopathy

G. Boriani, B. Maron, W. Shen, 2004 .

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

M. Link, B. Maron, M. Maron, 2003, Circulation.

The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?

B. Maron, M. Maron, I. Olivotto, 2006, European heart journal.

Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy.

W. Roberts, B. Maron, R. Cannon, 1992, Journal of the American College of Cardiology.

[Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations].

G. Breithardt, E. Aliot, J. Camm, 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy

Joydeep Ghosh, B. Maron, J. Francis, 2005, Indian pacing and electrophysiology journal.

Evidence for decreasing occurrence of sudden cardiac death associated with the marathon.

B. Maron, W. Roberts, 2005, Journal of the American College of Cardiology.

Causes of Sudden Death During the Triathlon—Reply

B. Maron, K. Harris, Jason T. Henry, 2010 .

Cardiac arrest in a young marathon runner

B. Maron, N. Ratliff, C. Gornick, 2002, The Lancet.

The ESC Risk Score is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity.

B. Maron, M. Maron, E. Rowin, 2019, The Canadian journal of cardiology.

Implications of hypertrophic cardiomyopathy transmitted by sperm donation.

H. Rehm, B. Maron, N. Schiller, 2009, JAMA.

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy

M. Desai, J. Towbin, B. Maron, 2022 .

Editorial : Myocardial Fiber Disarray and Ventricular Septal Hypertrophy In Asymmetrical Hypertrophy of the Heart

W. Henry, B. Maron, S. Epstein, 2022 .

Electrocardiographic evidence of left ventricular hypertrophy in otherwise normal children. Clarification by echocardiography.

L. J. Krovetz, W. Henry, B. Maron, 1975, The American journal of cardiology.

Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.

Barry J Maron, Christine E Seidman, J. Seidman, 2004, Journal of the American College of Cardiology.

Genetics of Hypertrophic Cardiomyopathy After 20 Years

B. Maron, M. Maron, C. Semsarian, 2012 .

Glycogen Storage Diseases and Cardiomyopathy

B. Maron, M. Arad, 2010 .

What Constitutes an "Academic" Cardiology Practice? There Are New Models to Consider.

B. Maron, K. Harris, W. Katsiyiannis, 2015, The American journal of cardiology.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2000, The New England journal of medicine.

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2022, Heart.

Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy

B. Maron, H. Karvounis, V. Vassilikos, 2016, Journal of cardiovascular medicine.

Hypertrophic cardiomyopathy in China.

B. Maron, 2007, The American journal of cardiology.

Two husbands--one disease: the broad clinical spectrum of hypertrophic cardiomyopathy.

B. Maron, S. Sharkey, S. Casey, 2002, The American journal of cardiology.

Hypertrophic Cardiomyopathy and Coronary Arteries

B. Maron, 2002 .

Aborted Sudden Cardiac Death in Hypertrophic Cardiomyopathy

B. Maron, D. Rosenbaum, A. Almquist, 1999, Journal of cardiovascular electrophysiology.

Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.

Shengshou Hu, S. Ommen, B. Maron, 2022, Journal of the American College of Cardiology.

Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice.

B. Maron, M. Maron, E. Rowin, 2020, The American journal of cardiology.

LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators.

B. Maron, M. Maron, 2016, JACC. Cardiovascular imaging.

The Father of Septal Myectomy for Obstructive HCM, Who Also Had HCM: The Unbelievable Story.

W. Roberts, B. Maron, 2016, Journal of the American College of Cardiology.

Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.

N. Smedira, M. Desai, S. Ommen, 2015, Journal of the American College of Cardiology.

Hypertrophic cardiomyopathy in the developing world: focus on India.

B. Maron, A. Kalra, 2014, European heart journal.

The 25-Year Genetic Era in Hypertrophic Cardiomyopathy: Revisited

B. Maron, M. Maron, 2014, Circulation. Cardiovascular genetics.

Hypertrophic cardiomyopathy in childhood: the gradient is not the disease. Excessive use of experimental invasive interventions.

B. Maron, M. Maron, 2013, Journal of the American College of Cardiology.

Hypertrophic cardiomyopathy centers.

B. Maron, 2009, The American journal of cardiology.

Common Variant on Chromosome 9p21 Predicts Severity of Coronary Artery Disease

B. Maron, M. Maron, J. Lesser, 2011 .

Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, Circulation.

Global Burden of Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, JACC. Heart failure.

Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, The American journal of cardiology.

Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, R. Chan, 2017, The American journal of cardiology.

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

H Niimura, A E Chudley, J. Seidman, 1998, The New England journal of medicine.

Late-onset primary LVHHCM versus cardiac fabry variant: reply

J. Seidman, B. Maron, C. Seidman, 2002 .

Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.

D. Corrado, B. Maron, S. Rizzo, 2019, Journal of the American College of Cardiology.

Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy.

W. Roberts, B. Maron, S. Epstein, 1987, Zeitschrift fur Kardiologie.

Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

B. Maron, P. Spirito, Y. Wesley, 1986, The New England journal of medicine.

Relation Between Extent of Left Ventricular Hypertrophy a Diastolic Filling Abnormalities i Y ertr is

B. Maron, P. Spirito, 2016 .

Hypertrophic Cardiomyopathy Morphology and Significance of the Left Ventricular Collagen Network in Young Patients With Hypertrophic Cardiomyopathy and Sudden Cardiac Death

W. Roberts, B. Maron, J. Shirani, 2016 .

Methods for Distinguishing Athlete’s Heart from Structural Heart Disease, with Emphasis on Hypertrophic Cardiomyopathy

B. Maron, 1997 .

Evolution of Left Ventricular Hypertrophy in Patients with Hypertrophic Cardiomyopathy

B. Maron, 1990 .

Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

B. Maron, M. Maron, 2015, Circulation.

CLINICAL SIGNIFICANCE OF LATE GADOLINIUM ENHANCEMENT AT RIGHT VENTRICULAR ATTACHMENT TO VENTRICULAR SEPTUM IN HYPERTROPHIC CARDIOMYOPATHY

W. Manning, C. Autore, B. Maron, 2014 .

The Young Competitive Athlete: Causes of Sudden Death, Detection, Preparticipation Screening, and Standards for Disqualification with Cardiovascular Abnormalities

B. Maron, 1997 .

Sudden Cardiac Death in Competitive Athletes

B. Maron, 1997 .

Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2019, The American journal of cardiology.

Risk for sudden cardiac death associated with marathon running.

B. Maron, W. Roberts, L. Poliac, 1996, Journal of the American College of Cardiology.

Cardiovascular Disease in Ankylosing (Marie-Strümpell) Spondylitis

B. Maron, A. Ansari, 1997 .

Apical hypertrophic cardiomyopathy: the continuing saga.

B. Maron, Barry J. Maron, Barry J Maron, 1990, Journal of the American College of Cardiology.

Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes.

B. Maron, A. Pelliccia, A. Biffi, 2008, The American journal of cardiology.

Cardiac lymphoma mimicking hypertrophic cardiomyopathy.

W. Roberts, B. Maron, G. Vasudevan, 1981, American heart journal.

Revisiting arrhythmic risk after alcohol septal ablation: is the pendulum finally swinging…back to myectomy?

B. Maron, R. Nishimura, 2014, JACC. Heart failure.

Controversy in 2014 Surgical Septal Myectomy Versus Alcohol Septal Ablation: Assessing the Status of the

B. Maron, R. Nishimura, 2014 .

that it contained the underlying study of his first catheter- based treatment of HOCM.

B. Maron, M. Henein, D. Fassbender, 2010 .

Medical and surgical therapy of hypertrophic cardiomyopathy.

R. Bonow, B. Maron, M. Leon, 1988, Cardiovascular clinics.

Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports.

M. Proschan, B. Maron, A. Pelliccia, 1994, The American journal of cardiology.

Long-term postoperative prognosis of patients with congenital heart disease. Clinical conference from the Cardiology Branch of the National Heart, Lung, and Blood Institute.

B. Maron, S. Epstein, R. Goldstein, 1977, Chest.

Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

B. Maron, C. Kimmelstiel, 2004, Circulation.

Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present.

W. Roberts, B. Maron, E. Braunwald, 2022, The American journal of cardiology.

Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, The American journal of cardiology.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH 7 ( βMyosin βMyosin βMyosin Heavy Chain )Versus )Versus )Versus MYBPC 3 ( MyosinBinding MyosinBinding MyosinBinding Protein C )Related )Related )Related Hypertrophic Cardiomyopathy

W. Manning, B. Maron, M. Maron, 2017 .

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Barry J Maron, Harry Rakowski, Christine E Seidman, 2011, Circulation.

Back to the Future: Predicting Sudden Death in Hypertrophic Cardiomyopathy Relyingon Individual Risk Markers and Physician Judgment Without Mathematical Scoring.

B. Maron, M. Maron, E. Rowin, 2020, Heart rhythm.

Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy.

B. Maron, M. Maron, E. Rowin, 2020, The American journal of cardiology.

Importance and feasibility of creating hypertrophic cardiomyopathy centers in developing countries: the experience in India.

B. Maron, 2015, The American journal of cardiology.

Racial Frequencies in Congenital Heart Disease

L. J. Krovetz, B. Maron, J. M. Applefeld, 1973, Circulation.

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

B. Maron, P. Bruzzi, K. M. Harris, 2000, The New England journal of medicine.

Reply: To PMID 24630786.

C. Autore, B. Maron, P. Spirito, 2014, The American journal of cardiology.

Hypertrophic cardiomyopathy with longevity to 90 years or older.

B. Maron, J. Lesser, R. Garberich, 2012, The American journal of cardiology.

Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.

B. Maron, J. Lesser, Tammy S. Haas, 2010, The American journal of cardiology.

Dr. Gunnar Thor Gunnarsson and hypertrophic cardiomyopathy: what "giving back" means.

B. Maron, 2010, The American journal of cardiology.

Multicenter Study of the Efﬁcacy and Safety of Disopyramide in Obstructive Hypertrophic Cardiomyopathy

B. Maron, I. Barač, W. McKenna, 2005 .

Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes.

B. Maron, Mosi K. Bennett, K. Harris, 2020, The American journal of cardiology.

Drug-induced toxic myocarditis.

B. Maron, A. Ansari, Daniel G Berntson, 2003, Texas Heart Institute journal.

Human heart and platelet actins are products of different genes.

B. Maron, M. Elzinga, R. Adelstein, 1976, Science.

Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.

W. Manning, B. Maron, M. Maron, 2009, Journal of the American College of Cardiology.

Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy

B. Maron, N. Pandian, M. Maron, 2017, Echocardiography.

Tunnel Subaortic Stenosis: Left Ventricular Outflow Tract Obstruction Produced by Fibromuscular Tubular Narrowing

W. Roberts, W. Henry, B. Maron, 1976, Circulation.

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

B. Maron, I. Olivotto, F. Cecchi, 1995, Journal of the American College of Cardiology.

Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.

M. Josephson, B. Maron, R. Watson, 1987, Journal of the American College of Cardiology.

Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.

F O Mueller, W. Roberts, B. Maron, 1996, JAMA.

Sudden death and other risks associated with dry-sand beach holes.

B. Maron, B. Maron, 2001, Journal of the American Medical Association (JAMA).

The preparticipation physical examination: steps toward consensus and uniformity.

G. Matheson, B. Maron, D. W. Glover, 1999, The Physician and sportsmedicine.

Cardiovascular Screening of High School Athletes—Reply

B. Maron, D. W. Glover, 1999 .

The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2020, Journal of the American College of Cardiology.

Clinical implications for molecular genetics of cardiomyopathy

J. Seidman, B. Maron, C. Seidman, 2005 .

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd

Barry J Maron, Arthur J Moss, Charles Antzelevitch, 2006, Circulation.

Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Luigi Rega, Giovanni Quarta, Giancarlo Casolo, 2008, Journal of the American College of Cardiology.

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Barry J Maron, Harry Rakowski, Christine E Seidman, 2011, Circulation.

Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, P. Spirito, 2018, Circulation.

Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).

B. Maron, S. Betocchi, M. Galderisi, 2006, The American journal of cardiology.

M. Link, B. Maron, A. Adabağ, 2005, Journal of the American College of Cardiology.

839-1 The long-term effect of surgical myectomy on survival in patients with obstructive hypertrophic cardiomyopathy

B. Gersh, S. Ommen, B. Maron, 2004 .

Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy

W. Roberts, B. Maron, H. Klues, 1992, Circulation.

Myotomy-Myectomy for Relief of Left Ventricular Outflow Tract

B. Maron, R. Cannon, H. Klues, 2005 .

Comparison of mitral valve dimensions in adults with valvular aortic stenosis, pure aortic regurgitation and hypertrophic cardiomyopathy.

M. Proschan, W. Roberts, B. Maron, 1993, The American journal of cardiology.

Sudden Death in Patients with Hypertrophic Cardiomyopathy

B. Maron, S. Epstein, 1980 .

Truncus arteriosus malformation in a human embryo.

G. Hutchins, B. Maron, Barry J. Maron, 1972, The American journal of anatomy.

"Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years.

B. Maron, M. Maron, J. Lesser, 2011, The American journal of cardiology.

Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death.

W. Roberts, B. Maron, J. Shirani, 2000, Journal of the American College of Cardiology.

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

W. Roberts, B. Maron, S. Epstein, 1986, Journal of the American College of Cardiology.

Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy.

B. Maron, D. Aeppli, D. Hurrell, 2003, The American journal of cardiology.

Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States

B. Maron, M. Maron, A. Zenovich, 2005, Circulation.

The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction.

B. Maron, R. Kloner, S. Sharkey, 2018, Circulation.

Evidence That High Catecholamine Levels Produced by Pheochromocytoma May be Responsible for Tako-Tsubo Cardiomyopathy.

B. Maron, S. Sharkey, D. Dassenko, 2015, The American journal of cardiology.

Cardiology Patient Page. Takotsubo (stress) cardiomyopathy.

B. Maron, J. Lesser, S. Sharkey, 2011, Circulation.

Hypertrophic cardiomyopathy: a common cause of sudden death in the young competitive athlete.

W. Roberts, B. Maron, S. Epstein, 1983, European heart journal.

Sudden death while playing professional football.

W. Roberts, B. Maron, Barry J. Maron, 1981, American heart journal.

Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy.

W. Roberts, B. Maron, R. Cannon, 1993, The American journal of cardiology.

Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

R. Bonow, B. Maron, S. Epstein, 1987, The American journal of cardiology.

Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy.

B. Maron, F. Cecchi, H. Klues, 1993, The American journal of cardiology.

Hypertrophic cardiomyopathy: an overview.

B. Maron, S. Epstein, 1980, Clinical and investigative medicine. Medecine clinique et experimentale.

Recurrence of a discrete subaortic membrane 27 years after operative resection.

B. Maron, D. Nicoloff, L. Poliac, 1995, The American journal of cardiology.

Reply: Nonobstructive Hypertrophic Cardiomyopathy: Low Mortality but Not Always Benign.

B. Maron, M. Maron, 2016, Journal of the American College of Cardiology.

Abstract 14017: Contemporary Management Strategies Provide Low Mortality Rates for Young Patients with Hypertrophic Cardiomyopathy

M. Link, B. Maron, M. Maron, 2014 .

Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

E. D. Wigle, Judith S. Hochman, Mark A. Hlatky, 2003 .

Significance and relationship between magnitude of left ventricular hypertrophy and congestive heart failure symptoms in hypertrophic cardiomyopathy

B. Maron, M. Maron, S. Casey, 2002 .

Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy.

Barry J Maron, Perry M Elliott, Greg Whyte, 2002, Journal of the American College of Cardiology.

Upper limits of physiologically induced left ventricular cavity enlargement due to athletic training.: 1078

B. Maron, A. Pelliccia, A. Biffi, 1995 .

The electrocardiogram in supravalvular aortic stenosis.

B. Maron, N. J. Sissman, 1971, American heart journal.

Development and Determinants of Dynamic Obstruction to Left Ventricular Outflow in Young Patients With Hypertrophic Cardiomyopathy

B. Maron, J. Panza, T. Maris, 1992, Circulation.

Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy.

B. Maron, A. Pelliccia, P. Spirito, 1995, Circulation.

Feline hypertrophic cardiomyopathy: gross anatomic and quantitative histologic features.

B. Maron, L. Tilley, S. K. Liu, 1981, The American journal of pathology.

Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement.

M. Link, B. Maron, W. Roberts, 2007, Journal of athletic training.

Asymmetry in hypertrophic cardiomyopathy: the septal to free wall thickness ratio revisited.

B. Maron, 1985, The American journal of cardiology.

Spontaneous echo contrast and thromboembolism.

B. Maron, A. Ansari, A. Ansari, 1997, Hospital practice.

Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2016 .

925-43 Hypertrophic Cardiomyopathy in Tuscany: More Benign Clinical Course and Outcome in an Unselected Regional Population

B. Maron, F. Cecchi, G. Santoro, 1995 .

Ultrastructural aspects of contractile proteins in cardiac hypertrophy and failure.

V. Ferrans, B. Maron, M. Jones, 1976, Recent advances in studies on cardiac structure and metabolism.

Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm

B. Maron, B. Knight, Kiam-Khiang Lim, 2009, Journal of cardiovascular electrophysiology.

Cardiovascular involvement in osteogenesis imperfecta.

J. Hanley, B. Maron, P. Tsipouras, 1986, Circulation.

The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.

E. Braunwald, B. Maron, M. Maron, 2009, Journal of the American College of Cardiology.

Genetic Screening of Sperm and Oocyte Donors : Ethical and Policy Implications

B. Maron, N. Schiller, J. Lesser, 2011 .

Intermediate-Signal-Intensity Late Gadolinium Enhancement Predicts Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy

Francesca N. Delling, W. Manning, B. Maron, 2012, Circulation. Cardiovascular imaging.

2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy

W. Manning, B. Maron, M. Maron, 2008 .

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardi

R. Passman, S. Hohnloser, W. Stevenson, 2008, Circulation.

Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy

Warren J Manning, Barry J Maron, W. Manning, 2008, Circulation. Heart failure.

Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.

W. Manning, B. Maron, A. Adabağ, 2008, Journal of the American College of Cardiology.

A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention

R. Passman, S. Hohnloser, W. Stevenson, 2008 .

merican Heart Association/American College of Cardiology oundation/Heart Rhythm Society Scientific Statement on oninvasive Risk Stratification Techniques for Identifying atients at Risk for Sudden Cardiac Death

D. Siscovick, A. Kadish, J. Goldberger, 2008 .

Classification, Epidemiology, and Global Burden of Cardiomyopathies.

B. Maron, G. Thiene, W. McKenna, 2017, Circulation research.

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

E. Cook, M. Pencina, W. Manning, 2014, Circulation.

Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

A. Tajik, B. Gersh, S. Ommen, 2007, Journal of the American College of Cardiology.

Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques.

R. Bonow, B. Maron, P. Spirito, 1986, Journal of the American College of Cardiology.

Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, Barry J. Maron, 1990, Journal of the American College of Cardiology.

Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function.

B. Maron, P. Spirito, 1988, British heart journal.

Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy.

R. Bonow, B. Maron, P. Spirito, 1987, Journal of the American College of Cardiology.

Noninvasive assessment of left ventricular diastolic function: comparative analysis of pulsed Doppler ultrasound and digitized M-mode echocardiography.

B. Maron, F. Chiarella, C. Vecchio, 1986, The American journal of cardiology.

Effects of Verapamil on Left Ventricular Systolic Function and Diastolic Filling in Patients with Hypertrophic Cardiomyopathy

Michael V. Green, R. Bonow, B. Maron, 1981, Circulation.

Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes

Michael A. Burke, J. Seidman, B. Maron, 2017, Circulation. Cardiovascular genetics.

Sickle cell trait associated with sudden death in competitive athletes.

B. Maron, E. Eichner, Tammy S. Haas, 2012, The American journal of cardiology.

New perspectives on the prevalence of hypertrophic cardiomyopathy.

Barry J Maron, Christopher Semsarian, B. Maron, 2015, Journal of the American College of Cardiology.

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

M. Yacoub, J. Loscalzo, B. Maron, 2021, Nature Communications.

Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.

B. Maron, R. Desnick, M. Maron, 2017, The American journal of medicine.

Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

J. Seidman, B. Maron, H. Watkins, 1995, Nature Genetics.

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2021, Scientific Reports.

Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.

J. Seidman, B. Maron, H. Watkins, 1997, Journal of the American College of Cardiology.

Clinical Course and Management of Hypertrophic Cardiomyopathy

B. Maron, Barry J. Maron, 2018, The New England journal of medicine.

Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy.

B. Maron, L. Yeates, C. Semsarian, 2011, The American journal of cardiology.

Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.

B. Maron, R. Schwartz, M. Maron, 2014, The American journal of cardiology.

Nationwide Study on Hypertrophic Cardiomyopathy in Iceland: Evidence of a MYBPC3 Founder Mutation

Michael A. Burke, D. Gudbjartsson, K. Stefánsson, 2014, Circulation.

Septicemia following traumatic or incidental splenectomy.

B. Maron, J. Maloney, Maron Bj, 1972, The Johns Hopkins medical journal.

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

J. Seidman, J. Saul, B. Maron, 2005, The New England journal of medicine.

Isolation and Characterization of Myosin from Subjects with Asymmetric Sepatal Hypertrophy

V. Ferrans, B. Maron, R. Adelstein, 1977, Circulation research.

Intranuclear glycogen deposits in human cardiac muscle cells: ultrastructure and cytochemistry.

W. Roberts, V. Ferrans, B. Maron, 1975, Journal of molecular and cellular cardiology.

Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings.

W. Roberts, V. Ferrans, W. Henry, 1974, Circulation.

Disproportionate Ventricular Septal Thickening in the Developing Normal Human Heart

B. Maron, J. Verter, S. Kapur, 1978, Circulation.

Asymmetric Septal Hypertrophy

W. Roberts, V. Ferrans, W. Henry, 1974 .

Prevalence and Characteristics of Disproportionate Ventricular Septal Thickening in Patients with Acquired or Congenital Heart Diseases: Echocardiographic and Morphologic Findings

W. Henry, B. Maron, S. Epstein, 1977, Circulation.

Myofibrillar abnormalities following cardiac muscle cell injury.

V. Ferrans, B. Maron, L. Buja, 1975, Recent advances in studies on cardiac structure and metabolism.

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.

W. Roberts, B. Maron, S. Epstein, 1982, Circulation.

The case for surgery in obstructive hypertrophic cardiomyopathy.

B. Gersh, S. Ommen, B. Maron, 2004, Journal of the American College of Cardiology.

Group of the National Heart, Lung, and Blood Institute Research Priorities in Hypertrophic Cardiomyopathy : Report of a Working

B. Byrne, S. Houser, S. Ommen, 2011 .

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

B. Byrne, S. Houser, S. Ommen, 2010, Circulation.

Special Report Research Priorities in Hypertrophic Cardiomyopathy Report of a Working Group of the National Heart, Lung, and Blood Institute Genetic Cause

B. Byrne, S. Houser, S. Ommen, 2010 .

Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation.

M. Link, B. Maron, A. Alsheikh-Ali, 2009, Heart rhythm.

Sudden death and the competitive athlete: perspectives on preparticipation screening studies.

B. Maron, S. Epstein, S. Epstein, 1986, Journal of the American College of Cardiology.

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

Barry J Maron, Christopher Semsarian, B. Maron, 2012, Journal of the American College of Cardiology.

Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly

J. Seidman, B. Maron, C. Seidman, 2002, Circulation.

Asymmetric Septal Hypertrophy in Childhood

W. Roberts, W. Henry, B. Maron, 1976, Circulation.

Recommendations for interpretation of 12-lead electrocardiogram in the athlete.

Barry J Maron, Hein Heidbuchel, Pietro Delise, 2009, European heart journal.

Arrhythmias and Sudden Death in Athletes

B. Maron, D. Zipes, A. Luna, 2000, Developments in Cardiovascular Medicine.

Prevalence and clinical significance of left atrial remodeling in competitive athletes.

B. Maron, S. Caselli, A. Pelliccia, 2005, Journal of the American College of Cardiology.

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

M. Proschan, B. Maron, A. Pelliccia, 1991, The New England journal of medicine.

Hypertrophic cardiomyopathy in the dog.

B. Maron, L. Tilley, S. K. Liu, 1979, The American journal of pathology.

Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.

H Niimura, J. Seidman, B. Maron, 2001, Journal of the American College of Cardiology.

Left atrial-to-right atrial shunt without atrial septal defect or precordial murmur. Pulmonary varix and hypertrophic cardiomyopathy.

W. Roberts, B. Maron, D. Schwartz, 1982, Chest.

Hypertrophic Cardiomyopathy in Infants: Clinical Features and Natural History

W. Roberts, B. Maron, T. Graham, 1982, Circulation.

Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance.

B. Maron, E. Louie, 1986, Journal of the American College of Cardiology.

Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

B. Maron, E. Ciró, P. Spirito, 1983, The American journal of cardiology.

Identification of Congenital Malformations of the Great Arteries in Infants by Real‐time Two‐dimensional Echocardiography

J. Griffith, W. Henry, B. Maron, 1975, Circulation.

Differential Diagnosis of Anomalies of the Great Arteries by Real,time Two,dimensional Echocardiography

J. Griffith, W. Henry, B. Maron, 1975 .

Incidence and causes of sudden death in U.S. college athletes.

B. Maron, Tammy S. Haas, Aneesha Ahluwalia, 2014, Journal of the American College of Cardiology.

Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet.

B. Maron, S. Epstein, S. Epstein, 1980, The American journal of cardiology.

Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.

W. Roberts, B. Maron, B. Waller, 1983, Circulation.

26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities

B. Maron, Jere H. Mitchell, 1994 .

Asymptomatic sinus of Valsalva aneurysm causing right ventricular outflow obstruction before and after rupture.

W. Roberts, B. Maron, M. Jones, 1984, The American journal of cardiology.

Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes.

D. Corrado, B. Maron, G. Thiene, 2000, Journal of the American College of Cardiology.

Sudden Death in Young Athletes

W. Roberts, B. Maron, S. Epstein, 1980, Circulation.

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2001, Circulation.

Posterior cardiac displacement by anterior mediastinal tumor.

J. Gottdiener, B. Maron, 1980, Chest.

Harvey Feigenbaum, MD, and the Creation of Clinical Echocardiography: A Conversation With Barry J. Maron, MD.

B. Maron, 2017, The American journal of cardiology.

Arrhythmogenic Right Ventricular Cardiomyopathy Causing Sudden Cardiac Death in Boxer Dogs: A New Animal Model of Human Disease

Jeffrey A. Towbin, J. Towbin, B. Maron, 2004, Circulation.

Unusual complications of meningococcal meningitis.

B. Maron, K. Macoul, P. Benaron, 1972, The Johns Hopkins medical journal.

Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation.

J. Seidman, B. Maron, D. Fatkin, 1999, The American journal of cardiology.

Unusual Evolution of Acquired Infundibular Stenosis in Patients with Ventricular Septal Defect: Clinical and Morphologic Observations

B. Maron, R. White, Victor J. Ferrans, 1973, Circulation.

Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance.

W. Roberts, B. Maron, B J Maron, 1981, American heart journal.

Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum of Patients with Hypertrophic Cardiomyopathy

W. Roberts, B. Maron, B J Maron, 1979, Circulation.

Nongenetically transmitted disproportionate ventricular septal thickening associated with left ventricular outflow obstruction.

J. Gottdiener, W. Roberts, B. Maron, 1979, British heart journal.

Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography.

J. Gottdiener, B. Maron, S. Epstein, 1985, Journal of the American College of Cardiology.

Racial variations in the childhood electrocardiogram: preliminary observations.

L. J. Krovetz, B. Maron, B J Maron, 1972, American heart journal.

Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment.

B. Maron, E. Louie, B J Maron, 1987, Annals of internal medicine.

Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy).

R. Bonow, W. Roberts, B. Maron, 1982, The American journal of cardiology.

The 2006 American Heart Association Classification of Cardiomyopathies Is the Gold Standard

B. Maron, Barry J. Maron, 2008, Circulation. Heart failure.

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.

B. Maron, P. Elliott, M. Sherrid, 2005, Journal of the American College of Cardiology.

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

B. Maron, I. Olivotto, F. Cecchi, 2002, Journal of the American College of Cardiology.

Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

B. Maron, S. Epstein, D. Savage, 1979, Circulation.

Postoperative Assessment of Patients with Ventricular Septal Defect and Pulmonary Hypertension: Response to Intense Upright Exercise

B. Maron, J. Hirshfeld, D. Redwood, 1973, Circulation.

Ventricular and Supraventricular Tachyarrhythmias Associated with Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2012 .

Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

L. Pickle, B. Maron, J. Mulvihill, 1984, The American journal of cardiology.

Long-Term Hemodynamic and Electrocardiographic Assessment Following Operative Repair of Tetralogy of Fallot

B. Maron, S. Epstein, K. Kent, 1978, Circulation.

Hypertrophic cardiomyopathy

B. Maron, M. Maron, 2013, The Lancet.

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

M. Link, B. Gersh, C. Yancy, 2011, The Journal of thoracic and cardiovascular surgery.

Coexistence of asymmetric and symmetric left ventricular hypertrophy in a family with hypertrophic cardiomyopathy.

W. Roberts, B. Maron, E. Ciró, 1982, American heart journal.

Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

B. Maron, L. Fananapazir, J. Panza, 1992, Journal of the American College of Cardiology.

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.

B. Maron, S. Epstein, D. Savage, 1981, The American journal of cardiology.

Quantitative Analysis of the Distribution of Cardiac Muscle Cell Disorganization in the Left Ventricular Wall of Patients with Hypertrophic Cardiomyopathy

W. Roberts, B. Maron, BARRY J. MARON, 1981, Circulation.

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

W. Roberts, B. Maron, S. Epstein, 1979, The American journal of cardiology.

Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.

B. Maron, Jannet F. Lewis, J. Lewis, 1989, Journal of the American College of Cardiology.

Familial spontaneous complete heart block in hypertrophic cardiomyopathy.

B. Maron, E. Louie, 1986, British heart journal.

Spontaneously Occurring Hypertrophic Cardiomyopathy in Dogs and Cats: A Potential Animal Model of a Human Disease

B. Maron, L. Tilley, S. K. Liu, 1982 .

Hypertrophic cardiomyopathy and complete heart block in infancy.

W. Roberts, B. Maron, T. M. Connor, 1981, American heart journal.

Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction

W. Roberts, B. Maron, H. Klues, 1991, Circulation.

The development of the semilunar valves in the human heart.

G M Hutchins, G. Hutchins, B. Maron, 1974, The American journal of pathology.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.

B. Maron, R. Kovacs, D. Zipes, 2015, Journal of the American College of Cardiology.

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.

D. Atkins, W. Strong, B. Maron, 1996, Circulation.

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

K. P. Carney, B. Maron, M. Sherrid, 2003, Journal of the American College of Cardiology.

Sudden death in young athletes.

B. Maron, 1980, The New England journal of medicine.

Prospective echocardiographic screening for coronary artery anomalies in 1,360 elite competitive athletes.

B. Maron, A. Pelliccia, A. Spataro, 1993, The American journal of cardiology.

Sudden death during the triathlon.

B. Maron, Tammy S. Haas, K. Harris, 2010, JAMA.

Triggers for sudden cardiac death in the athlete.

B. Maron, Barry J. Maron, 1996, Cardiology clinics.

Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

C. Tracy, B. Maron, M. Leon, 1987, Journal of the American College of Cardiology.

Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006

B. Maron, F. Mueller, David M. Tierney, 2009, Circulation.

Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation

B. Wessler, B. Maron, M. Maron, 2021, Circulation. Arrhythmia and electrophysiology.

Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2019, The American journal of cardiology.

Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

M. Link, L. Price, B. Maron, 2019, The American journal of cardiology.

86 – Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: Sudden Death, Risk Stratification, and Prevention With Implantable Defibrillators

B. Maron, M. Maron, 2018 .

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

M. Link, B. Maron, M. Maron, 2017, Circulation.

Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2017, American Journal of Cardiology.

Significance of eft Atrial Remodeling in Competitive Athletes

B. Maron, S. Caselli, A. Biffi, 2016 .

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Barry J Maron, Iacopo Olivotto, Christopher Semsarian, 2014, Journal of the American College of Cardiology.

Barry J Maron, Harry Rakowski, Christine E Seidman, 2011, Journal of the American College of Cardiology.

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

A. Angelini, B. Maron, S. Iliceto, 2010, European heart journal.

Contemporary Reviews in Cardiovascular Medicine Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, 2010 .

Contemporary Reviews in Cardiovascular Medicine Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, 2010 .

Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, 2009, Journal of cardiovascular translational research.

Barry Joel Maron, MD: a conversation with the Editor. Interview by William Clifford Roberts.

W. Roberts, B. Maron, 2007, The American journal of cardiology.

Implications of Arrhythmias and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, A. Adabağ, 2007, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Practice Guidelines Consensus Documents and the European Society of Cardiology Committee for

B. Maron, C. Seidman, W. McKenna, 2007 .

Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.

M. Link, B. Maron, M. Maron, 2005, The American journal of cardiology.

Surgery for Hypertrophic Obstructive Cardiomyopathy: Alive and Quite Well

B. Maron, 2005, Circulation.

Chapter 29 – Arrhythmias Associated with Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2005 .

Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?

G. Boriani, B. Maron, W. Shen, 2004, Circulation.

Hypertrophic cardiomyopathy in childhood.

B. Maron, 2004, Pediatric clinics of North America.

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

Barry J Maron, Folkert J Ten Cate, Christine E Seidman, 2003, Journal of the American College of Cardiology.

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

C. Tracy, S. Priori, S. Kaul, 2003, European heart journal.

Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

B. Maron, M. Maron, S. Betocchi, 2003, The New England journal of medicine.

Hypertrophic Cardiomyopathy Clinical Profile of Stroke in 900 Patients With Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2001 .

Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

B. Maron, I. Olivotto, F. Cecchi, 2000, Circulation.

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

B. Maron, D. Aeppli, A. Almquist, 1999, JAMA.

Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population

B. Maron, I. Olivotto, F. Cecchi, 1998, Heart.

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.

B. Maron, H. Klues, Andreas Schiffers, 1995, Journal of the American College of Cardiology.

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest.

B. Maron, S. Epstein, F. Cecchi, 1989, Journal of the American College of Cardiology.

A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity.

B. Maron, H. Watkins, C. Reggiani, 1998, Circulation research.

Sexual Activity and Cardiovascular Disease : A Scientific Statement From the

J. Conti, E. Ohman, B. Maron, 2012 .

Sexual Activity and Cardiovascular Disease : A Scientific Statement From the American

J. Conti, E. Ohman, B. Maron, 2012 .

Coexistence of passive and active junctional rhythms with rates up to 300 per minute in a child with atrial parasystole.

B. Maron, M. Mirowski, B. B. Bell, 1973, Chest.

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

J. Gottdiener, B. Maron, S. Epstein, 1981, The American journal of cardiology.

Failure of Commercially Available Chest Wall Protectors to Prevent Sudden Cardiac Death Induced by Chest Wall Blows in an Experimental Model of Commotio Cordis

Barry J Maron, Jonathan Weinstock, M. Link, 2006, Pediatrics.

Evaluation of chest barriers for protection against sudden death due to commotio cordis.

Barry J Maron, M. Link, B. Maron, 2007, The American journal of cardiology.

Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis).

N G Pandian, M. Link, B. Maron, 1999, Circulation.

Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy”

W. Manning, B. Maron, M. Ackerman, 2009 .

Hypertrophic cardiomyopathy with left ventricular apical diverticulum.

W. Roberts, B. Maron, R. Hauser, 1996, The American journal of cardiology.

The differential diagnosis of anomalies of the great vessels by real-time, two-dimensional echocardiography

J. Griffith, W. Henry, B. Maron, 1974 .

Commotio Cordis and the Epidemiology of Sudden Death in Competitive Lacrosse

M. Link, J. Hodges, B. Maron, 2009, Pediatrics.

Clinical profile and spectrum of commotio cordis.

M. Link, B. Maron, N. Estes, 2002, JAMA.

Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis.

N G Pandian, M. Link, B. Maron, 2001, Journal of the American College of Cardiology.

Cardiac muscle cell disorganization in the ventricular septum: Evidence from quantitative histology that it is a highly sensitive marker of hypertrophic cardiomyopathy

W. Roberts, B. Maron, S. Epstein, 1978 .

Current operative treatment of obstructive hypertrophic cardiomyopathy.

B. Maron, C. Mcintosh, C. L. McIntosh, 1988, Circulation.

Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy.

R. Bonow, B. Maron, R. Cannon, 1989, Circulation.

Sudden death in young athletes. Lessons from the Hank Gathers affair.

B. Maron, 1993, The New England journal of medicine.

Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy.

R. Bonow, B. Maron, R. Cannon, 1984, The American journal of cardiology.

Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > or = 65 years of age.

B. Maron, J. Lewis, 1994, The American journal of cardiology.

Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome.

J. Gottdiener, W. Roberts, B. Maron, 1982, The American journal of medicine.

Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disea

A. Moss, J. Towbin, B. Maron, 1998, Circulation.

Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum: Comparison of Fetuses and Infants with and Without Congenital Heart Disease and Patients with Hypertrophic Cardiomyopathy

J E Edwards, W. Roberts, B. Maron, 1979, Circulation.

Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Barry J Maron, James S Hodges, J. Hodges, 2010, Journal of the American College of Cardiology.

Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.

Barry J Maron, Antonio Spataro, D. Corrado, 2006, European heart journal.

Epidemiology of Sudden Death in Young, Competitive Athletes Due to Blunt Trauma

J. Hodges, B. Maron, R. Cantu, 2011, Pediatrics.

Profile of preparticipation cardiovascular screening for high school athletes.

B. Maron, D. W. Glover, 1998, JAMA.

Gene Mutations in Apical Hypertrophic Cardiomyopathy

J. Seidman, B. Maron, C. Seidman, 2005, Circulation.

Sudden death due to neck blows among amateur hockey players.

W. Hall, B. Maron, A. Ashare, 2003, JAMA.

Causes of sudden death in competitive athletes.

W. Roberts, B. Maron, S. Epstein, 1986, Journal of the American College of Cardiology.

Foundation/American Heart Association Task Force on Practice Guidelines Cardiomyopathy : A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic

B. Gersh, J. Towbin, S. Ommen, 2011 .

Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy

Michael Jerosch-Herold, Carsten Rickers, Norbert M. Wilke, 2005, Circulation.

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome.

J. Towbin, B. Maron, M. Ackerman, 2005, Journal of the American College of Cardiology.

Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy

S. Solomon, J. Seidman, B. Maron, 2002, Circulation.

The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited

B. Maron, B J Maron, 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Outer limits of the athlete's heart, the effect of gender, and relevance to the differential diagnosis with primary cardiac diseases.

B. Maron, A. Pelliccia, 1997, Cardiology clinics.

Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse

B. Maron, J. Isner, W. McKenna, 1994 .

Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.

B. Maron, A. Pelliccia, A. Spataro, 1993, British heart journal.

Peculiar focal myocardial degeneration and fatal ventricular arrhythmias in a child.

R. Rowe, G. Hutchins, B. Maron, 1972, The New England journal of medicine.

Association of secundum atrial septal defect and atrioventricular nodal dysfunction. A genetically transmitted syndrome.

B. Maron, S. Epstein, A. Damato, 1978, British heart journal.

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.

R. Bonow, B. Maron, P. O'Gara, 1989, Circulation.

Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning

B. Maron, A. Pelliccia, A. Spataro, 2002, Circulation.

Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience.

B. Maron, A. Pelliccia, 1995, The American journal of cardiology.

Sudden infant death syndrome (SIDS): cardiac pathologic observations in infants with SIDS.

B. Maron, R. Fisher, 1977, American heart journal.

Sudden unexpected death 12 years after "near-miss" sudden infant death syndrome in infancy.

W. Roberts, B. Maron, J. Marraccini, 1986, The American journal of cardiology.

Potential Role of QT Interval Prolongation in Sudden Infant Death Syndrome

B. Maron, S. Epstein, R. Goldstein, 1976, Circulation.

Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis).

Wei Zhu, Barry J Maron, Paul J. Wang, 2003, Journal of the American College of Cardiology.

[Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations].

G. Breithardt, E. Aliot, J. Camm, 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

Obstructive Hypertrophic Cardiomyopathy

B. Maron, Charles L. Mclntosh, 2005 .

Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil.

R. Bonow, B. Maron, M. Green, 1987, Journal of the American College of Cardiology.

Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy.

R. Bonow, B. Maron, S. Epstein, 1986, Journal of the American College of Cardiology.

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

Michael V. Green, V. Dilsizian, R. Bonow, 1985, Circulation.

Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.

B. Maron, M. Pozzoli, R. Tramarin, 1985, Circulation.

Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis.

V. Dilsizian, R. Bonow, B. Maron, 1991, The American journal of cardiology.

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

S. Larson, R. Bonow, B. Maron, 1987, Circulation.

Structural features of the athlete heart as defined by echocardiography.

B. Maron, 1986, Journal of the American College of Cardiology.

The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR.

B. Maron, M. Maron, 2016, JACC. Cardiovascular imaging.

The 20 advances that have defined contemporary hypertrophic cardiomyopathy.

B. Maron, M. Maron, 2015, Trends in cardiovascular medicine.

Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

B. Maron, Y. Doi, H. Kitaoka, 2003, The American journal of cardiology.

Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities.

B. Maron, L. Poliac, R. Mathenge, 1999, Journal of the American College of Cardiology.

Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.

B. Maron, A. Pelliccia, A. Spataro, 1996, JAMA.

Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease.

B. Maron, P. Fox, S. K. Liu, 1995, Circulation.

Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

W J McKenna, B. Maron, F. Cecchi, 1994, British heart journal.

Surviving competitive athletics with hypertrophic cardiomyopathy.

B. Maron, H. Klues, Barry J. Maron, 1994, The American journal of cardiology.

Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.

B. Maron, M. Maron, J. E. Peterson, 1994, The American journal of cardiology.

Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs.

W. Roberts, B. Maron, S. K. Liu, 1993, The American journal of cardiology.

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

B. Maron, P. Spirito, 1993, The American journal of cardiology.

Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy.

W. Roberts, B. Maron, H. Klues, 1993, Journal of the American College of Cardiology.

Echocardiographic Assessment of Mitral Valve Size in Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen

M A Proschan, M. Proschan, W. Roberts, 1993, Circulation.

Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing “athlete's heart” from hypertrophic cardiomyopathy

B. Maron, A. Pelliccia, Jannet F. Lewis, 1992, British heart journal.

Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography.

B. Maron, J. Panza, H. Klues, 1992, Journal of the American College of Cardiology.

Intraventricular muscle band mimicking asymmetric ventricular septal hypertrophy and hypertrophic cardiomyopathy.

B. Maron, H. Klues, C. Mcintosh, 1992, The American journal of cardiology.

Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass.

W. Roberts, B. Maron, A. H. Kragel, 1990, British heart journal.

The giant negative T wave revisited ... in hypertrophic cardiomyopathy.

B. Maron, 1990, Journal of the American College of Cardiology.

Utility of Intraoperative Echocardiography in Planning Surgical Strategy in Obstructive Hypertrophic Cardiomyopathy

B. Maron, C. Mcintosh, G. Greenberg, 1990 .

Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes.

B. Maron, J. Lewis, C. Curry, 1989, The American journal of cardiology.

Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood.

B. Maron, J. Panza, 1989, The American journal of cardiology.

Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease.

B. Maron, E. Tucker, K. J. Green, 1987, Journal of the American College of Cardiology.

Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy.

B. Maron, R. Watson, P. Spirito, 1987, The American journal of cardiology.

Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1987, Journal of the American College of Cardiology.

Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.

Michael V. Green, R. Bonow, B. Maron, 1983, Circulation.

Characteristics of the cardiac hypertrophy in Friedreich's ataxia.

J. Gottdiener, B. Maron, R. J. Hawley, 1982, American heart journal.

Distribution and Significance of Cardiac Muscle Cell Disorganization in the Left Ventricle of Patients with Hypertrophic Cardiomyopathy: Evidence of a Diffuse Cardiomyopathic Process

W. Roberts, B. Maron, 1982 .

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration.

R. Bonow, B. Maron, M. Leon, 1981, The American journal of cardiology.

Hypertrophic cardiomyopathy: a discussion of nomenclature.

B. Maron, S. Epstein, 1979, The American journal of cardiology.

Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise.

R. Bonow, B. Maron, S. Bacharach, 1990, Circulation.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2007, JAMA.

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

M. Link, B. Maron, N. Pandian, 2006, Circulation.

Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view.

B. Maron, 1983, British heart journal.

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

R. Bonow, B. Maron, M. Leon, 1988, The New England journal of medicine.

Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects.

Michael V. Green, R. Bonow, B. Maron, 1988, Journal of the American College of Cardiology.

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1990, Journal of the American College of Cardiology.

The "Guidant Affair": 15 years later.

B. Maron, N. Estes, 2020, Heart rhythm.

Lessons From the Failure and Recall of an Implantable Cardioverter-Defibrillator

Robert G. Hauser, B. Maron, R. Hauser, 2005, Circulation.

Cardiac evaluation of collegiate student athletes: a medical and legal perspective.

Peter F. Lake, J. Seward, A. Tajik, 2012, The American journal of medicine.

Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism Endorsed by the American College of Cardi

B. Maron, M. Mitten, G. Balady, 2007, Circulation.

Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations.

B. Maron, D. Zipes, 2005, Journal of the American College of Cardiology.

Update of the guidelines on sudden cardiac death of the European Society of Cardiology.

Panos Vardas, Silvia G Priori, Barry J Maron, 2003, European heart journal.

Strychnine poisoning successfully treated with diazepam.

B. Maron, B. Tune, J. Krupp, 1971, The Journal of pediatrics.

Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016

B. Maron, L. Creswell, R. Garberich, 2017, Annals of Internal Medicine.

Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

B. Maron, 2007 .

Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1989, Journal of the American College of Cardiology.

The paradox of exercise.

B. Maron, B J Maron, 2000, The New England journal of medicine.

Cost‐Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias

A. Moss, W. Zareba, B. Maron, 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy.

M. Proschan, W. Roberts, B. Maron, 1994, Journal of the American College of Cardiology.

Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation.

W. Roberts, B. Maron, R. Cannon, 1993, The American journal of cardiology.

Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

W. Manning, B. Maron, C. O’Donnell, 2010, The American journal of cardiology.

Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

W. Manning, B. Maron, Jacqueline Buros, 2008, The American journal of cardiology.

Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

W. Manning, B. Maron, M. Maron, 2006, Circulation.

Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function.

R. Bonow, B. Maron, R. E. Clark, 1985, Circulation.

Serial Long‐term Assessment of the Natural History of Asymptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Systolic Function

R. Bonow, B. Maron, S. Epstein, 1991, Circulation.

Survival andfunctional results after valve replacement foraortic regurgitation from1976to 1983: impact ofpreoperative left ventricular function

B. Maron, S. Epstein, A. Picone, 2011 .

Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation.

R. Bonow, B. Maron, R. E. Clark, 1988, Circulation.

Left ventricular end diastolic pressure, suspected underlying hypertrophic cardiomyopathy, and takotsubo syndrome – reply.

B. Maron, S. Sharkey, 2014, Circulation journal : official journal of the Japanese Circulation Society.

catechol-Left Ventricular End Diastolic Pressure, Suspected Underlying Hypertrophic Cardiomyopathy, and Takotsubo Syndrome

B. Maron, S. Sharkey, 2014 .

Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, P. Spirito, 2008, Journal of cardiovascular electrophysiology.

Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association.

J. Conti, E. Ohman, B. Maron, 2012, Circulation.

Sudden cardiac death in hypertrophic cardiomyopathy.

B. Maron, L. Fananapazir, 1992, Circulation.

Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.

B. Gersh, S. Ommen, B. Maron, 2010, The American journal of cardiology.

Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.

M. Link, J. Daubert, B. Maron, 2009, The American journal of cardiology.

Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.

D. Corrado, B. Maron, G. Thiene, 2009, European heart journal.

cardiomyopathydeath and prevention in hypertrophic Contemporary considerations for risk stratification

B. Maron, 2008 .

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

B. Maron, M. Kuskowski, A. Adabağ, 2005, Journal of the American College of Cardiology.

Chapter 64 – Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

B. Maron, Barry J Maron, 2004 .

Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

B. Maron, D. Aeppli, R. Hauser, 2003, Journal of the American College of Cardiology.

Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy

B. Maron, 2003, Heart.

Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, P. Bernabò, 2003, The American journal of cardiology.

Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.

B. Maron, O. Rimoldi, M. Maron, 2021, International journal of cardiology.

Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy

M. Link, B. Maron, M. Maron, 2017, Circulation. Arrhythmia and electrophysiology.

Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

M. Link, B. Maron, M. Maron, 2015, Journal of the American College of Cardiology.

Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy: Under-Recognized Subset of Candidates for Heart Transplant

W. Roberts, B. Maron, M. Maron, 2014, Circulation. Heart failure.

Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance

E. Cook, M. Pencina, W. Manning, 2014 .

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

M. Link, E. Ashley, G. Boriani, 2013, Journal of the American College of Cardiology.

The case for myocardial ischemia in hypertrophic cardiomyopathy.

Barry J Maron, Sanjay K Prasad, Iacopo Olivotto, 2009, Journal of the American College of Cardiology.

Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.

W. Roberts, B. Maron, M. Maron, 2008, The American journal of cardiology.

Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy

B. Maron, S. Iliceto, G. Thiene, 2007, Heart.

Determinants for clinical diagnosis of hypertrophic cardiomyopathy.

B. Maron, M. Kuskowski, A. Adabağ, 2006, American Journal of Cardiology.

Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.

B. Maron, A. Almquist, Tammy S. Haas, 2005, Heart rhythm.

Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy.

B. Maron, A. Zenovich, K. Harris, 2005, The American journal of cardiology.

Impact of Postgraduate Medical Education on Recognition of Stroke

B. Maron, B. Maron, J. Easton, 2005, Cardiology in review.

Can sudden cardiac death be prevented?

B. Maron, 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Society for Cardiovascular Pathology Symposium 2009 Can sudden cardiac death be prevented

B. Maron, 2010 .

Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

A. Tajik, B. Gersh, S. Ommen, 2005, Journal of the American College of Cardiology.

Hypertrophic and Dilated Cardiomyopathy Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy

A. Tajik, B. Gersh, S. Ommen, 2005 .

ong-Term Effects of Surgical Septal yectomy on Survival in Patients With bstructive Hypertrophic Cardiomyopathy

A. Tajik, B. Maron, H. Schaff, 2005 .

Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).

B. Maron, P. Okin, R. Devereux, 2004, The American journal of cardiology.

Screening for hypertrophic cardiomyopathy in a young male military population.

D. Corrado, B. Maron, G. Thiene, 2003, The American journal of cardiology.

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2001, Current cardiology reports.

Implications of left ventricular remodeling in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1998, The American journal of cardiology.

Hypertrophic cardiomyopathy, myocarditis, and other myopericardial diseases and mitral valve prolapse

B. Maron, J. Isner, W. McKenna, 1994 .

Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement.

Barry J Maron, Jonathan A Drezner, William O Roberts, 2007, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

Inter Association Task Force Recommendations on Emergency Preparedness andManagement of Sudden Cardiac Arrest in High School andCollege Athletic Programs: A Consensus Statement

M. Link, B. Maron, W. Roberts, 2007, Heart rhythm.

Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.

W. Manning, B. Maron, M. Maron, 2013, Journal of the American College of Cardiology.

Automated External Defibrillator Arrhythmia Detection in a Model of Cardiac Arrest due to Commotio Cordis

Paul J. Wang, M. Link, B. Maron, 2003, Journal of cardiovascular electrophysiology.

There is No Reason to Adopt ECGs and Abandon American Heart Association/American College of Cardiology History and Physical Screening for Detection of Cardiovascular Disease in the Young

B. Maron, P. Thompson, M. Maron, 2019, Journal of the American Heart Association.

Ethics of preparticipation cardiovascular screening for athletes

B. Maron, A. Caplan, Richard A. Friedman, 2015, Nature Reviews Cardiology.

National Electrocardiography Screening for Competitive Athletes: Feasible in the United States?

Barry J Maron, B. Maron, 2010, Annals of Internal Medicine.

Death and Cardiac Arrest in U.S. Triathlon Participants

B. Maron, L. Creswell, K. Harris, 2018, Annals of Internal Medicine.

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, B. Maron, P. Bruzzi, 2009, Circulation.

Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).

M. Josephson, R. Kieval, B. Maron, 1999, Circulation.

B. Maron, R. Kovacs, D. Zipes, 2015, Circulation.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13 Commotio Cordis A Scientific Statement From the American Heart Association and American College of Cardiology

M. Link, B. Maron, N. Mark Estes, 2015, Circulation.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.

M. Link, B. Maron, N. Estes, 2015, Journal of the American College of Cardiology.

Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years.

B. Maron, 2015, The American journal of cardiology.

Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12 – 25 Years of Age)

Paul Kligfield, J. Saul, S. Viskin, 2014 .

Prevalence and Clinical Significance of Aortic Root Dilation in Highly Trained Competitive Athletes

B. Maron, A. Pelliccia, F. Culasso, 2010, Circulation.

Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening

B. Maron, Barry J. Maron, 2009, British Journal of Sports Medicine.

Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography.

B. Maron, R. Schwartz, J. Lesser, 2009, JACC. Cardiovascular imaging.

Does preparticipation cardiovascular screening of athletes save lives?

B. Maron, 2007, Nature Clinical Practice Cardiovascular Medicine.

The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death.

Barry J Maron, B. Maron, A. Pelliccia, 2006, Circulation.

[Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].

B. Maron, 2006, Revista espanola de cardiologia.

Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7

Barry J Maron, Christine E Seidman, J. Seidman, 2006, Circulation.

The Athlete’s Heart: Remodeling, Electrocardiogram And Preparticipation Screening

B. Maron, A. Pelliccia, F. D. Di Paolo, 2002, Cardiology in review.

Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort.

B. Maron, M. Maron, R. Crow, 2001, The American journal of cardiology.

Abstract 14156: Risk Stratification and Outcome of Patients with Hypertrophic Cardiomyopathy Over 60 Years of Age: Does Age Count?

B. Maron, M. Maron, E. Rowin, 2011 .

Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes.

M. Link, B. Maron, A. Pelliccia, 2014, Heart rhythm.

B. Maron, B. Levine, R. Kovacs, 2015, Circulation.

Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.

M. Desai, J. Towbin, B. Maron, 2022, Journal of the American College of Cardiology.

Outcomes in athletes with marked ECG repolarization abnormalities.

B. Maron, G. Thiene, C. Basso, 2008, The New England journal of medicine.

Prevalence and Characteristics of Disproportionate Ventricular Septal Thickening in Infants with Congenital Heart Disease

B. Maron, S. Epstein, J. Moller, 1979 .

Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes.

B. Maron, D. Aeppli, T. E. Gohman, 1998, Journal of the American College of Cardiology.

Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

B. Maron, R. Garberich, Tammy S. Haas, 2016, The American journal of medicine.

Incidence of cardiovascular sudden deaths in Minnesota high school athletes.

B. Maron, Tammy S. Haas, Aneesha Ahluwalia, 2013, Heart rhythm.

Counterpoint: Mandatory ECG screening of young competitive athletes.

B. Maron, 2012, Heart rhythm.

Cardiovascular Disease, Sudden Cardiac Death, and Preparticipation Screening in Young Competitive Athletes

B. Maron, 2012 .

Cardiovascular Abnormalities in Competitive Athletes: 2007 Update : Recommendations and Considerations Related to Preparticipation Screening for

B. Maron, M. Mitten, G. Balady, 2012 .

Diversity of views from Europe on national preparticipation screening for competitive athletes.

B. Maron, 2010, Heart rhythm.

Electrocardiography and Preparticipation Screening of Competitive High School Athletes

B. Maron, 2010 .

Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.

J. Hodges, B. Maron, P. Thompson, 2009, The American journal of cardiology.

Brief Communication: Cardiovascular Screening Practices of Major North American Professional Sports Teams

B. Maron, A. Hutter, K. Harris, 2006, Annals of Internal Medicine.

Preparticipation Cardiovascular Screening for Young Athletes

B. Maron, J. Puffer, G. C. Pfister, 2000 .

Preparticipation cardiovascular screening for US collegiate student-athletes.

B. Maron, J. Puffer, G. C. Pfister, 2000, JAMA.

Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course.

B. Maron, M. Maron, E. Rowin, 2020, The American journal of cardiology.

Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy

W. Manning, B. Maron, M. Maron, 2010, Circulation.

Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy.

W. Roberts, B. Maron, B J Maron, 1992, The American journal of cardiology.

Participation in Recreational Sports for Young Patients with Genetic Cardiovascular Diseases

B. Maron, 2010 .

Increasing survival rate from commotio cordis.

M. Link, B. Maron, N. Estes, 2013, Heart rhythm.

Erratum: Task force on sudden cardiac death of the European society of cardiology (European Heart Journal (2001) 22 (1374-1450))

G. Breithardt, A. Camm, E. Aliot, 2002 .

Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2017, Circulation. Heart failure.

How should we screen competitive athletes for cardiovascular disease?

B. Maron, 2005, European heart journal.

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators

G. Boriani, C. Autore, B. Maron, 2018, Circulation. Arrhythmia and electrophysiology.

Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement.

W. Roberts, B. Maron, R. Wallace, 1982, American heart journal.

Frequency and significance of M-mode echocardiographic evidence of mitral valve prolapse in clinically isolated pure mitral regurgitation: analysis of 65 patients having mitral valve replacement.

J. Gottdiener, W. Roberts, B. Maron, 1984, The American journal of cardiology.

Refractory hypochromic anemia in malignant lymphoma.

B. Maron, N. Shahidi, 1970, The Journal of pediatrics.

Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?

S. Ommen, B. Maron, M. Maron, 2014, Journal of the American College of Cardiology.

Pitfalls in the echocardiographic diagnosis of isolated non-compaction of the ventricular myocardium

B. Maron, E. Arteaga, B J Maron, 2005, Heart.

Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs.

Barry J Maron, Natesa G Pandian, Paul J. Wang, 2002, Pediatrics.

Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.

W. Manning, C. Autore, W. Roberts, 2015, The American journal of cardiology.

Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle.

B. Maron, B. Maron, 2017, JACC. Cardiovascular imaging.

Shared decision-making in HCM

B. Maron, M. Maron, R. Nishimura, 2017, Nature Reviews Cardiology.

Onset of apical hypertrophic cardiomyopathy in adulthood.

B. Maron, J. Lesser, Tammy S. Haas, 2011, The American journal of cardiology.

Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, B. Maron, 2016, The American journal of cardiology.

Ethical, legal, and practical considerations impacting medical decision-making in competitive athletes.

B. Maron, M. Mitten, A. Caplan, 1994, Medicine and science in sports and exercise.

Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.

B. Maron, S. Caselli, N. Pandian, 2014, The American journal of cardiology.

Evolution in the process of screening United States high school student-athletes for cardiovascular disease.

B. Maron, D. W. Glover, Drew Glover, 2007, The American journal of cardiology.

Abstract 3872: Profile and Frequency of Sudden Deaths in 1,463 Young Competitive Athletes: From a 25-year U.S. National Registry, 1980 2005

B. Maron, F. Mueller, David M. Tierney, 2006 .

Competitive athletes with cardiovascular disease--the case of Nicholas Knapp.

B. Maron, M. Mitten, D. Zipes, 1998, The New England journal of medicine.

Management of hypertrophic cardiomyopathy.

W. Mckenna, B. Maron, C. Seidman, 1993 .

Images in cardiovascular medicine. Extreme left ventricular hypertrophy.

B. Maron, B. Gross, S. Stark, 1995, Circulation.

Causes of sudden death in competitive athletes: Correction

W. Roberts, B. Maron, S. Epstein, 1986 .

Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy

J. Cohn, B. Maron, D. Duprez, 2004, Circulation.

Why we need more septal myectomy surgeons: An emerging recognition

N. Smedira, M. Desai, S. Ommen, 2017, The Journal of thoracic and cardiovascular surgery.

Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines.

B. Maron, 2012, Progress in cardiovascular diseases.

Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.

M. Yacoub, B. Maron, J. Dearani, 2011, European heart journal.

Myths about surgical myectomy: rumors of its death have been greatly exaggerated.

S. Ommen, B. Maron, R. Nishimura, 2008, The American journal of cardiology.

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?

S. Ommen, B. Maron, M. Maron, 2007, Journal of the American College of Cardiology.

Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle.

B. Maron, R. Nishimura, G. Danielson, 1998, Circulation.

Crisscrossed atrioventricular valves and prolonged survival.

W. Roberts, B. Maron, R. Shemin, 1982, The American journal of cardiology.

Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.

D. Peters, W. Manning, B. Maron, 2011, Radiology.

Functional assessment of left ventricular ejection dynamics by cine-magnetic resonance imaging in hypertrophic cardiomyopathy.

A. Dwyer, R. Bonow, B. Maron, 1994, The American journal of cardiology.

Medical and legal issues in the cardiovascular evaluation of competitive athletes.

B. Maron, G. Fletcher, T. Paterick, 2005, JAMA.

Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009

A. Capucci, H. Heidbuchel, B. Lindsay, 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy

B. Maron, M. Maron, R. Chan, 2015, BioMed research international.

Hypertrophic cardiomyopathy: an important global disease.

B. Maron, 2004, The American journal of medicine.

Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy.

B. Maron, C. Semsarian, 2010, European heart journal.

Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.

Barry J Maron, B. Maron, M. Maron, 2010, The American journal of cardiology.

How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.

B. Gersh, J. Towbin, S. Ommen, 2009, Circulation. Cardiovascular genetics.

From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy

B. Maron, M. Ackerman, S. V. Van Driest, 2003, Heart.

Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle.

B. Maron, R. Nishimura, U. Sigwart, 1999, Circulation.

Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".

B. Maron, M. Maron, E. Rowin, 2018, Circulation.

Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy

B. Maron, L. Køber, E. Orav, 2009, Circulation. Cardiovascular genetics.

Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes.

B. Maron, Tammy S. Haas, K. Harris, 2015, Journal of the American College of Cardiology.

Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy?

B. Maron, M. Maron, E. Rowin, 2019, Trends in cardiovascular medicine.

Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2021, The American journal of cardiology.

Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, R. Chan, 2018, The American journal of medicine.

Reply: Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm.

B. Maron, M. Maron, E. Rowin, 2017, Journal of the American College of Cardiology.

Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies

B. Maron, M. Maron, E. Rowin, 2016, Circulation.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.

B. Maron, P. Thompson, E. Eichner, 2015, Journal of the American College of Cardiology.

Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.

S. Colan, B. Maron, R. Kwong, 2011, The American journal of cardiology.

Intramitochondrial gylcogen deposits in hypertrophied human myocardium.

V. Ferrans, B. Maron, 1975, Journal of molecular and cellular cardiology.

The occurrence of α-glycogen in human cardiac muscle cells

V. Ferrans, B. Maron, 1974 .

The spectrum of degenerative changes in hypertrophied human cardiac muscle cells: an ultrastructural study.

V. Ferrans, B. Maron, M. Jones, 1975, Recent advances in studies on cardiac structure and metabolism.

Spherical microparticles in human myocardium: an ultrastructural study.

W. Roberts, V. Ferrans, B. Maron, 1976, Laboratory investigation; a journal of technical methods and pathology.

Molecular epidemiology of hypertrophic cardiomyopathy.

J. Seidman, B. Maron, C. Seidman, 2002, Cold Spring Harbor symposia on quantitative biology.

Canine hypertrophic cardiomyopathy.

B. Maron, L. Tilley, S. Liu, 1979, Journal of the American Veterinary Medical Association.

Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity.

W. Roberts, B. Maron, S. Epstein, 1981, Chest.

Cardiovascular preparticipation screening of competitive athletes: addendum: an addendum to a statement for health professionals from the Sudden Death Committee (Council on Clinical Cardiology) and the Congenital Cardiac Defects Committee (Council on Cardiovascular Disease in the Young), American He

D. Atkins, W. Strong, B. Maron, 1998, Circulation.

Lutembacher's syndrome.

B. Maron, A. Ansari, 1997, Texas Heart Institute journal.

First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

B. Maron, J. Lesser, P. Sorajja, 2016, Journal of the American College of Cardiology.

Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes?

B. Maron, A. Baker, R. Garberich, 2016, The American journal of cardiology.

16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984.

J. Mitchell, B. Maron, S. Epstein, 1985, Journal of the American College of Cardiology.

A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.

B. Maron, M. Maron, E. Rowin, 2023, Cardiovascular Research.

Early descriptions of sudden cardiac death due to commotio cordis occurring in baseball.

B. Maron, N. Estes, S. Boren, 2010, Heart rhythm.

Relation of race to electrocardiographic patterns in elite American football players.

B. Maron, A. Magalski, M. Main, 2008, Journal of the American College of Cardiology.

Heterogeneous Morphologic Expression of Genetically Transmitted Hypertrophic Cardiomyopathy: Two–dimensional Echocardiographic Analysis

B. Maron, E. Ciró, P. F. Nichols, 1983, Circulation.

Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.

M. Link, W. Manning, B. Maron, 2012, The American journal of cardiology.

Eugene Braunwald, MD and the early years of hypertrophic cardiomyopathy: a conversation with Dr. Barry J. Maron.

E. Braunwald, B. Maron, 2012, The American journal of cardiology.

Prolapse of the mitral valve (floppy valve) associated with Ebstein's anomaly of the tricuspid valve

W. Roberts, B. Maron, S. Epstein, 1976 .

Acquired left ventricular endocardial constriction from massive mural calcific deposits: a newly recognized cause of impairment to left ventricular filling.

R. Bonow, W. Roberts, B. Maron, 1984, The American journal of cardiology.

Relation Between Extent of Left Ventricular Hypertrophy Hypertrophic Cardiomyopathy and Age in

B. Maron, P. Spirito, 2016 .

Operative treatment of pediatric obstructive hypertrophic cardiomyopathy: a 26-year experience.

B. Maron, R. E. Clark, H. Hennein, 1993, The Annals of thoracic surgery.

Hypertrophic cardiomyopathy compatible with successful completion of the marathon.

B. Maron, Y. Wesley, J. Arce, 1984, American Journal of Cardiology.

Longevity in elite athletes: the first 4-min milers

B. Maron, P. Thompson, 2018, The Lancet.

It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports.

B. Maron, D. Zipes, 2008, Heart rhythm.

The congenital long QT syndrome and implications for young athletes.

Jeffrey Kluger, Barry J Maron, B. Maron, 2006, Medicine and science in sports and exercise.

Super Recurrence of Takotsubo Syndrome: Clinical Characteristics and Late Cardiac Outcomes

B. Maron, Opema Lohese, B. Okeson, 2023, Journal of the American Heart Association.

Extreme hypertrophic cardiomyopathy

B. Maron, A. Almquist, S. Casey, 2003, Heart.

Obstructive vs nonobstructive asymmetric septal hypertrophy: Differences in left ventricular function with exercise

Michael V. Green, B. Maron, S. Epstein, 1978 .

Identical twins with hypertrophic cardiomyopathy and apical aneurysm.

B. Maron, A. Zenovich, J. Lesser, 2006, The American journal of cardiology.

Cardiac hypertrophy in athletes.

B. Maron, L. E. Ford, D. Oakley, 1984, British heart journal.

Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes.

B. Maron, R. Garberich, Tammy S. Haas, 2014, International journal of cardiology.

Left ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age

B. Maron, M. Maron, E. Rowin, 2018, Pacing and clinical electrophysiology : PACE.

Perspectives on cardiovascular screening.

B. Maron, J. Tfelt‐Hansen, B. Winkel, 2015, JAMA.

Electrocardiographic changes associated with training and discontinuation of training in an athlete with hypertrophic cardiomyopathy.

B. Maron, C. Basso, A. Pelliccia, 2004, The American journal of cardiology.

Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is Possible.

E. Braunwald, B. Maron, M. Maron, 2017, The American journal of medicine.

Precordial thumb ineffective in terminating ventricular fibrillation initiated by chest wall impact (commotio cordis)

M. Link, B. Maron, N. Estes, 2005 .

Reproducibility of Doppler echocardiographic measurements of left ventricular diastolic function.

B. Maron, P. Spirito, J. Merrill, 1988, European heart journal.

for Young Patients With Genetic Cardiovascular Diseases Recommendations for Physical Activity and Recreational Sports Participation

D. Corrado, B. Maron, B. Chaitman, 2007 .

New observations on the interrelation of dynamic subaortic obstruction and exercise in hypertrophic cardiomyopathy.

B. Maron, 1992, Journal of the American College of Cardiology.

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity

B. Maron, C. Berul, M. Maron, 2023, Heart rhythm O2.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

M. Senni, B. Maron, P. Bruzzi, 2015, Journal of the American College of Cardiology.

Development of endocardial valvuloids with valvular insufficiency.

G. Hutchins, B. Maron, 1972, Archives of pathology.

New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence.

B. Maron, 1999, European heart journal.

Q waves in hypertrophic cardiomyopathy: a reassessment.

B. Maron, B J Maron, 1990, Journal of the American College of Cardiology.

Perianesthetic Management of Hypertrophic Cardiomyopathy

B. Maron, L. Poliac, M. Barron, 2006 .

Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2019, Journal of cardiac failure.

Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.

M. Link, G. Boriani, B. Maron, 2013, Heart rhythm.

Lifetime Clinical Course of Hypertrophic Cardiomyopathy

B. Maron, M. Maron, F. Girolami, 2023, JACC. Advances.

Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten.

B. Maron, M. Maron, 2016, Mayo Clinic proceedings.

Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient.

W. Roberts, B. Maron, M. Maron, 2015, The American journal of cardiology.

Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype.

B. Maron, M. Maron, E. Rowin, 2020, European heart journal cardiovascular Imaging.

Reply: To PMID 25759101.

B. Maron, M. Maron, E. Rowin, 2015, The American journal of cardiology.

Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm.

B. Maron, M. Maron, E. Rowin, 2015, American Journal of Cardiology.

Hypertrophic Cardiomyopathy With Apical Aneurysm

B. Maron, A. Zenovich, J. Lesser, 2004 .

Comparison of phenotypic expression of hypertrophic cardiomyopathy in patients from the United States and Germany.

B. Maron, H. Klues, A. Schiffers, 1999, The American journal of cardiology.

What is commotio cordis?

M. Link, B. Maron, N. Estes, 1999, Cardiology in Review.

Morphological Determinants of Echocardiographic Patterns of Mitral Valve Systolic AnteriorMotion in Obstructive Hypertrophic Cardiomyopathy

W. Roberts, B. Maron, H. Klues, 1993, Circulation.

Variations in flow-velocity waveforms obtained by pulsed Doppler echocardiography in the normal human aorta.

B. Maron, E. Louie, K. J. Green, 1986, The American journal of cardiology.

Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young Athletes

B. Maron, 2007 .

Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy

B. Maron, 2000, The Lancet.

Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Iacopo Olivotto, Franco Cecchi, B. Maron, 2007 .

A phenocopy of sarcomeric hypertrophic cardiomyopathy: LAMP2 cardiomyopathy (Danon disease) from China.

B. Maron, 2012, European heart journal.

Catastrophic Injuries in High School and College Sports

B. Maron, 1996 .

Selective cine coronary arteriography and vectorcardiographic diagnose: correlative study of one hundred patients.

B. Maron, R. Selvester, E. Ellis, 1971, American Heart Journal.

Electrocardiographic Findings in Patients with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy

L. Horowitz, M. Josephson, E. Michelson, 1978, Circulation.

How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA.

B. Maron, M. Sherrid, M. Maron, 2023, International journal of cardiology.

J. Towbin, S. Ommen, R. Bonow, 2011 .

AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy : Executive summary

Christopher E. Buller, Judith S. Hochman, Harlan M. Krumholz, 2011 .

The management of hypertrophic cardiomyopathy.

W. Mckenna, B. Maron, C. Seidman, 1997, The New England journal of medicine.

Hypertrophic cardiomyopathy.

R. Bonow, B. Maron, S. Epstein, 1987, Disease-a-month : DM.

Sudden death from collapsing sand holes.

B. Maron, B. Maron, Tammy S. Haas, 2007, The New England journal of medicine.

RACIAL DIFFERENCES IN CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

B. Maron, M. Maron, E. Rowin, 2018 .

Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy with Pulmonary Hypertension.

B. Maron, D. Kleiner, M. Maron, 2022, Chest.

Risk of Hypertrophic Cardiomyopathy with Contemporary Management Strategies Implemented In Non-Referral Regional Community-Based Practices.

B. Maron, M. Maron, E. Rowin, 2020, The American journal of cardiology.

Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.

M. Yacoub, B. Maron, J. Dearani, 2011, European heart journal.

Contemporary Definitions and Classification of the Cardiomyopathies

A. Moss, J. Towbin, C. Antzelevitch, 2006 .

Task Force on Sudden Cardiac Death, European Society of Cardiology.

E. Aliot, J. Camm, S. Priori, 2002 .

Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2020, JACC. Clinical electrophysiology.

Hypertrophic Cardiomyopathy: New Concepts and Therapies.

B. Maron, M. Maron, E. Rowin, 2022, Annual review of medicine.

Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

B. Maron, M. Maron, N. Estes, 2023, Journal of the American College of Cardiology.

Defibrillation threshold testing in hypertrophic cardiomyopathy: As SIMPLE as possible but not simpler.

B. Maron, N. Estes, 2017, Heart rhythm.

Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

M. Link, B. Maron, M. Cheitlin, 2008 .

OUTCOMES OF SPORTS PARTICIPATION FOR PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: DATA FROM THE ICD SPORTS REGISTRY

M. Link, H. Heidbuchel, D. Cannom, 2020 .

Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature.

B. Maron, M. Maron, J. Lesser, 2011, Journal of the American College of Cardiology.

Response: How common is comorbid takotsubo syndrome in patients with acute coronary syndromes?

T. Henry, B. Maron, S. Sharkey, 2019, Catheterization and cardiovascular interventions.

Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2017, European heart journal.

Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?

B. Maron, M. Maron, E. Rowin, 2023, The American journal of cardiology.

An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Preventio

J. Baron, A. Moss, J. Towbin, 2006 .

Task Force on Sudden Cardiac Death, European Society of Cardiology.

E. Aliot, J. Camm, S. Priori, 2002 .

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

R. Bonow, B. Maron, M. Leon, 1985, Circulation.

Contemporary Reviews in Cardiovascular Medicine Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, 2010 .

Prevention of sudden death for patients with cardiomyopathies another step forward.

B. Maron, C. Semsarian, 2012, Journal of the American College of Cardiology.

William J. Bryant, B. Maron, M. Mitten, 2015, Journal of the American College of Cardiology.

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

B. Maron, M. Maron, C. Semsarian, 2012, Journal of the American College of Cardiology.

National Electrocardiography Screening for Competitive Athletes: Feasible in the United States?

B. Maron, 2010, Annals of Internal Medicine.

B. Maron, D. Zipes, A. Pelliccia, 2008, Journal of the American College of Cardiology.

Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12 – 25 Years of Age)

J. Saul, S. Viskin, B. Maron, 2014 .

Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.

B. Maron, Carolyn Y. Ho, 2009, JACC Cardiovascular Imaging.

Sudden death in young athletes.

B. Maron, 2003, New England Journal of Medicine.

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

B. Maron, M. Sherrid, Jannet F. Lewis, 2003, Journal of the American College of Cardiology.

Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations.

B. Maron, M. Mitten, 1994, Medicine & Science in Sports & Exercise.

Ethical, legal and practical considerations affecting medical decision-making in competitive athletes.

B. Maron, M. Mitten, A. Caplan, 1994, Journal of the American College of Cardiology.

Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

K. Siminovitch, W. Manning, B. Maron, 2014, European heart journal.

A phenocopy of sarcomeric hypertrophic cardiomyopathy: LAMP2 cardiomyopathy (Danon disease) from China.

B. Maron, 2012, European heart journal.

Apical Hypertrophic Cardiomyopathy: Clinical and Two-Dimensional Echocardiographic Assessment

B. Maron, E. Louie, 1987, Annals of internal medicine.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

J. Seidman, J. Saul, W. Roberts, 2009, JAMA.

How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.

B. Gersh, J. Towbin, S. Ommen, 2009, Circulation. Cardiovascular genetics.

Incidence and causes of sudden death in U.S. college athletes.

B. Maron, Tammy S. Haas, Aneesha Ahluwalia, 2014, Journal of the American College of Cardiology.

Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease

E. Braunwald, B. Maron, 2012, Circulation.

American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardi

R. Passman, S. Hohnloser, W. Stevenson, 2008, Heart rhythm.

Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes.

B. Maron, A. Pelliccia, A. Biffi, 2004, Journal of the American College of Cardiology.

New perspectives on the prevalence of hypertrophic cardiomyopathy.

B. Maron, M. Maron, C. Semsarian, 2015, Journal of the American College of Cardiology.

Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2018, Circulation.

Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.

M. Link, B. Maron, M. Maron, 2016, Journal of the American College of Cardiology.

Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.

D. Corrado, B. Maron, S. Rizzo, 2019, Journal of the American College of Cardiology.

Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy

B. Maron, M. Cheitlin, M. Maron, 2009 .

Increasing evidence that risk scores underperform in predicting sudden death in hypertrophic cardiomyopathy

B. Maron, M. Maron, E. Rowin, 2019, Heart.

Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten.

B. Maron, M. Maron, 2016, Mayo Clinic proceedings.

Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

B. Maron, D. Aeppli, R. Hauser, 2003, Journal of the American College of Cardiology.

Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular dis

A. Moss, J. Towbin, B. Maron, 1998, Circulation.

The case for myocardial ischemia in hypertrophic cardiomyopathy.

B. Maron, M. Maron, I. Olivotto, 2009, Journal of the American College of Cardiology.

In defense of antimicrobial prophylaxis for prevention of infective endocarditis in patients with hypertrophic cardiomyopathy.

B. Maron, H. Lever, 2009, Journal of the American College of Cardiology.

Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

S. Larson, R. Bonow, B. Maron, 1987, Circulation.

Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".

B. Maron, M. Maron, E. Rowin, 2018, Circulation.

Significance of Appropriate Defibrillator Shock 3 Hours and 20 Minutes Following Implantation in a Patient with Hypertrophic Cardiomyopathy

B. Maron, A. Almquist, Tammy S. Haas, 2008, Journal of cardiovascular electrophysiology.

Relation of race to electrocardiographic patterns in elite American football players.

B. Maron, A. Magalski, M. Main, 2008, Journal of the American College of Cardiology.

Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, R. Chan, 2017, The American journal of cardiology.

QRS Fragmentation as a Risk Marker for Sudden Death in Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, E. Rowin, 2023, JACC. Clinical electrophysiology.

Increasing survival rate from commotio cordis.

M. Link, B. Maron, N. Estes, 2013, Heart rhythm.

Marginal overlap between electrocardiographic abnormalities in patients with hypertrophic cardiomyopathy and trained athletes: Implications for preparticipation screening

D. Corrado, B. Maron, A. Pelliccia, 2007 .

Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009

Counterpoint/Mandatory ECG screening of young competitive athletes.

B. Maron, 2012, Heart rhythm.

D. Atkins, W. Strong, B. Maron, 1998, Circulation.

Sudden cardiac death in genetic heart diseases and the promise of prevention.

B. Maron, 2010, Revista espanola de cardiologia.

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

E. Cook, W. Manning, C. Autore, 2012 .

LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators.

B. Maron, M. Maron, 2016, JACC. Cardiovascular imaging.

Eugene Braunwald, MD and the early years of hypertrophic cardiomyopathy: a conversation with Dr. Barry J. Maron.

E. Braunwald, B. Maron, 2012, The American journal of cardiology.

Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy

B. Maron, M. Maron, 2015, Circulation.

Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common, and treatable disease (from the International Summit V).

B. Maron, 2014, The American journal of cardiology.

The first patient clinically diagnosed with hypertrophic cardiomyopathy.

E. Braunwald, R. Bonow, W. Roberts, 2008, The American journal of cardiology.

THE GUIDANT AFFAIR REVISITED…BUT THIS TIME WITH GOOD NEWS.

B. Maron, M. Maron, K. Harris, 2020, Heart rhythm.

Concerns About the HCM Risk-Kids Study.

B. Maron, M. Maron, E. Rowin, 2020, JAMA cardiology.

AORTIC REGURGITATION Cardiovascular involvement in osteogenesis imperfecta

J. Hanley, B. Maron, P. Tsipouras, 2005 .

Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.

B. Maron, M. Mitten, M. Maron, 2023, Journal of the American College of Cardiology.

To the editor--Participation screening for athletes.

B. Maron, Richard A. Friedman, 2014, Heart Rhythm.

Corrigendum to: ‘Recommendations for interpretation of 12-lead electrocardiogram in the athlete’ [Eur Heart J 2010;31:243–259]

M. Link, H. Heidbuchel, P. Schwartz, 2010 .

B. Maron, P. Thompson, E. Eichner, 2015, Circulation.

B. Maron, R. Kovacs, A. Braverman, 2015, Journal of the American College of Cardiology.

CorrespondenceResearch CorrespondenceWhy Not Just Call It Tako-Tsubo Cardiomyopathy: A Discussion of Nomenclature

B. Maron, M. Maron, J. Lesser, 2011 .

Novel frameshift mutation in Troponin C (TNNC1) associated with hypertrophic cardiomyopathy and sudden death

Barry J Maron, Wendy K Chung, W. Chung, 2011, Cardiology in the Young.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.

B. Maron, J. Isner, W. McKenna, 1994, Medicine and science in sports and exercise.

Coarctation of the aorta in the adult.

B. Maron, 1979, Cardiovascular clinics.

Ventricular septal crypt in hypertrophic cardiomyopathy.

B. Maron, J. Lesser, J. Lindberg, 2010, European heart journal.

Electrocardiogram in hypertrophic cardiomyopathy revisited: does ECG pattern predict phenotypic expression and left ventricular hypertrophy or sudden death?

B. Maron, K. Harris, S. Casey, 2002 .

M. Link, L. Cooper, R. Bonow, 2015, Circulation.

Prevalence and Characteristics of Disproportionate Ventricular Septal Thickening in Patients with Acquired or Congenital Heart Diseases: Echocardiographic and Morphologic Findings

W. Henry, B. Maron, S. Epstein, 1977, Circulation.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

M. Senni, B. Maron, P. Bruzzi, 2015, Journal of the American College of Cardiology.

Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?

B. Maron, M. Maron, C. Semsarian, 2015, Journal of the American College of Cardiology.

Abstract 13294: Evidence for Reduced Mortality in an Adult Cohort With Hypertrophic Cardiomyopathy

M. Link, B. Maron, M. Maron, 2013 .

Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far).

B. Maron, M. Maron, E. Rowin, 2022, The American journal of cardiology.

Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.

B. Maron, Carolyn Y. Ho, 2009, JACC. Cardiovascular imaging.

Response to Letter Regarding Article, “Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction”

M. Link, B. Maron, N. Pandian, 2007 .

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?

B. Maron, M. Maron, E. Rowin, 2023, Journal of the American Heart Association.

Massive cardiac ventricular scarring in first-degree relatives with hypertrophic cardiomyopathy.

W. Roberts, B. Maron, C. Warnes, 1984, The American journal of cardiology.

B. Maron, R. Kovacs, D. Zipes, 2015, Journal of the American College of Cardiology.

magnitude and significance athlete's heart: a clinical problem of increasing Distinguishing hypertrophic cardiomyopathy from

B. Maron, 2007 .

B. Maron, P. Thompson, E. Eichner, 2015, Circulation.

Early descriptions of sudden cardiac death due to commotio cordis occurring in baseball.

B. Maron, S. Boren, N. Estes, 2010, Heart rhythm.

Medical data, the media, and distortion of the facts in the internet era.

Barry J Maron, B. Maron, 2008, The American journal of cardiology.

Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2007 .

Diagnosis and management of hypertrophic cardiomyopathy

B. Maron, 2004 .

B. Maron, R. Kovacs, D. Zipes, 2015, Circulation.

Response to Letter Regarding Article, “Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy”

B. Maron, M. Maron, E. Rowin, 2012 .

Myocarditis in hypertrophic cardiomyopathy.

B. Maron, C. Basso, 2007, European heart journal.

Constitutively active AMP kinase mutations cause WPW and glycogen storage disease mimicking hypertrophic cardiomyopathy

J. Seidman, B. Maron, C. Seidman, 2002 .

END-STAGE HYPERTROPHIC CARDIOMYOPATHY REVISITED: IMPACT OF CONTEMPORARY THERAPIES

B. Maron, M. Maron, E. Rowin, 2019, Journal of the American College of Cardiology.